Grasp the capital flow this quarter and look at potential investors. There are 1457 potential investment and financing events in this quarter, including 437 in China and 1020 abroad. This article is a short version and a detailed version, please click: http://www.tmtpost.com/pro becomes a professional user of titanium media.

This quarter, the database of potential investment included 437 major domestic financing events, with a quarter-on-quarter increase of 14%.

From the field, there were 30 traffic trips, with 7.02 billion yuan; 151 cases of medical and health care, 5.871 billion yuan; Other 45 cases, 3.3 billion yuan; 4 financials, 3.296 billion yuan; 81 intelligent hardware, 3.052 billion yuan; 53 enterprise applications, 2.843 billion yuan; 64 artificial intelligence, 2.141 billion yuan; 8 express logistics, 1.7 billion yuan; 11 life services, 462 million yuan; 5 cases of agriculture, 440 million yuan; 8 Internet applications and services, RMB 321 million; 3 tools, RMB 168 million; 1 social event, 100 million RMB; 2 educations, 40 million RMB; 2 cultural entertainment, 40 million yuan; 1 case of government application, RMB 20 million; 1 trip, 20 million RMB; 1 autopilot, 20 million RMB; 3 big data, 20 million yuan; 2 blockchains, 7 million yuan; 1 home, 5 million yuan; 3 purchases, 0 RMB; 1 exercise and fitness, 0 RMB.

In terms of rounds, there are 9 rounds of D, with 958 million yuan; 61 angel wheels, 691 million RMB; 10 rounds of Pre-B, RMB 160 million; 1 round E, 0 RMB; 27 rounds of C, 7.136 billion yuan; One Pre-C+ round, 20 million RMB; 13 seed rounds, RMB 101 million; Angel wheel+7, 80 million RMB; 38 rounds of B, 3.066 billion yuan; 8 C+ rounds, 1.54 billion yuan; 11 Pre-A+ ships, 120 million RMB; 89 rounds A, 7.173 billion RMB; One case has not been defined, with RMB 180 million; 2 A++ rounds, 20 million RMB; 34 A+ rounds, 690 million RMB; 23 strategic investments, 883 million yuan; 6 D+ rounds, 200 million yuan; 74 Pre-A rounds, 1.425 billion RMB; 20 B+ rounds, 228 million RMB; 2 pre-IPOs, 220 million RMB.

Of the 437 financing events, 50 were over 100 million yuan, accounting for 0.84%. Among them, there are 20 cases of medical and health care, 9 cases of transportation, 9 cases of enterprise application, 8 cases of intelligent hardware, 3 cases of others, 3 cases of artificial intelligence, 3 cases of finance, 2 cases of express logistics, 2 cases of life service, 1 case of agriculture, 1 case of Internet application and service, 1 case of tools and 1 case of social interaction.

Regionally, there are 94 cases in Guangdong, 72 cases in Beijing, 67 cases in Jiangsu, 65 cases in Shanghai, 53 cases in Zhejiang, 14 cases in Anhui, 12 cases in Sichuan, 8 cases in Hubei, 6 cases in Fujian, 6 cases in Hunan, 6 cases in Shandong, 4 cases in Henan, 4 cases in Shaanxi, 4 cases in Hainan, 4 cases in Tianjin and 3 cases in Chongqing.

Traffic travel

Fujian Jingyan Zhitong Information Technology Co., Ltd. received nearly 10 million yuan in Pre-A round of financing.
Invested by Huaxin.

Nanjing jingweida automobile technology co., ltd. won over 100 million yuan in series a financing.
It is jointly invested by Yarui Capital and Daochun Capital.

Beijing Fengzhi Ruilian Technology Co., Ltd. received tens of millions of angel round financing.
Invested by Shanghai Huayi.

Nanjing Yingruichuang Electronic Technology Co., Ltd. received 500 million yuan in Series D financing.
It is jointly invested by mixed reform fund, Geely Holding, Guangzhou Automobile Capital, State Automobile Investment and Chendao Capital.

• In December, 2020, the company received a $20 million financing from C+ round, and the investor was Baolong Technology.

Chongqing Tailan New Energy Co., Ltd. received several hundred million yuan of Pre-B round financing.
It is jointly invested by CICC Capital, Zhengqi Holdings, Junlian Capital and Jilian Investment.

Heduo Technology (Beijing) Co., Ltd. received 300 million yuan of C+ round financing.
It is jointly invested by Yueke Finance and Guangzhou Automobile Capital.

• In October 2017, the company received $10 million in financing from Angel Wheel. The investors were IDG Capital, NavInfo, Zhixing Technology and Bertelsmann Asia Investment Fund.

The strategic investment financing of Changchun Yihang Intelligent Technology Co., Ltd.
It is invested by BAIC.

• In March 2019, the company received RMB 100 million in B+ round financing, and the investor was Guangzhou Automobile Group;
• In August, 2018, the company received a series B financing of RMB 220 million. The investors were Jingwei Venture Capital, CICC, Source Capital, Zhongjin Jiazi, Jingwei China and Zhongjin Jiacheng;
• In August 2016, the company obtained financing from Angel Wheel in undisclosed US dollars, and the investor was Mingshi Capital.

Zhejiang Geely Remote New Energy Commercial Vehicle Group Co., Ltd. received 600 million yuan in Series A financing.
It is jointly invested by Boyu Capital, Yuexiu Industrial Fund, Sichuan Linjiang Industrial Group, Yinshan Capital, Xiangtan Industrial Development Guidance Fund and United Clean Energy.

Zhili IOT (Hangzhou) Technology Co., Ltd. was awarded Series A financing.
Invested by the state power investment.

Beijing Micro-motion Space-time Technology Co., Ltd. received tens of millions of yuan in strategic investment and financing.
It is jointly invested by Century Capital, Yonggui Fund and Beijing Xinhangcheng.

• In December, 2021, the company received RMB 10 million financing from Angel Wheel, and the investors were Zhongke Chuangxing, Qiji Chuangtan and Venture Dark Horse Fund.

Tanwei Technology (Beijing) Co., Ltd. won the A+ round of financing.
It is jointly invested by Cornerstone Fund, Hechuang Zhiyuan, Guoxin Hongsheng and Zhongda Investment.

Beijing Sinian Zhijia Technology Co., Ltd. was awarded strategic investment financing.
Invested by the newly established group.

• In November, 2022, the company obtained A+ round financing of over RMB 100 million, and the investors were Shui Mu Venture Capital, Rongyi Investment, Chentao Capital, Guangfa Shunde, Hubin Capital and Zhihua Industry.

Shanghai Elabi Intelligent Technology Co., Ltd. won the B+ round of financing of over 100 million yuan.
Jointly invested by Juzhuo Capital and Guoke Xinneng.

• In September 2018, the company received RMB 10 million in Pre-A financing.

Deli New Energy Automobile Co., Ltd. received 100 million yuan in Series B financing.
It is jointly invested by Eucalyptus Capital, Guoxuan Hi-Tech, Huitong Network and Hongjing Electronics.

Guangdong Daoyuan Technology Co., Ltd. won the D+ round of financing.
Jointly invested by CDB Manufacturing Transformation and Upgrading Fund, Xinrui Jiyuan, Changjiang Capital, Yuexiu Industrial Fund, SDIC Investment Promotion and Suikai Investment.

Beijing Mawei Power Technology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Jiadao Private Capital and Weilai Capital.

Beijing Aotu Technology Co., Ltd. received several million yuan of seed round financing.
It is jointly invested by Zhenge Fund, Chuxin Capital and Li Yifan.

Jiangsu Lingyi Automobile Technology Co., Ltd. received 140 million yuan Pre-A round of financing.
It is jointly invested by Tianshan Capital, Lenovo Venture Capital and Xinyi Capital.

Zhejiang Xinruili Automobile Parts Co., Ltd. received 500 million yuan in Series B financing.
It is jointly invested by CICC Capital, Wenzhou Transportation Group, Haier Capital, Ruijian Venture Capital, Zhongsu Capital, Langfang State-owned Assets Group and Jihe Construction.

Shenzhen Qianhai Zhiyungu Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Qingxin Capital and Pengchen Investment.

Shenzhen Anyikong Power Technology Co., Ltd. received tens of millions of A+ rounds of financing.
Invested by Shenzhen Hi-tech.

Dream-chasing Sky Technology (Suzhou) Co., Ltd. received tens of millions of seed rounds of financing.
Jointly invested by Tengye Venture Capital and Shuimu Tsinghua Alumni Fund.

Shanghai Zhongdiao Information Technology Co., Ltd. received tens of millions of A++ rounds of financing.
Invested by Oriental Chase.

• In January 2016, the company received RMB 20 million in Pre-A financing, and the investor was Pepsi Group.

Shenzhen Kaisi Times Technology Co., Ltd. received 200 million yuan in D+ round financing.
It is jointly invested by Wuhu Xinyin Automobile Production and Investment Fund, Fengyuan Capital, Guangyue Investment, Shenzhen Hi-tech Investment and Xinghang SDIC.

• In October, 2019, the company obtained the financing of $80 million in Series C. The investors were Sequoia Capital China, Source Capital and Huaye Tiancheng.
• In August 2018, the company obtained B+ round financing exceeding RMB 250 million, and the investors were Wuyuan Capital, Shanghai Joint Venture Capital, Fosun Ruizheng and Shunwei Capital;
• In April 2018, the company received a B+ round of financing of RMB 250 million. The investors were Fosun Ruizheng Capital, Zuoyu Capital, Hua Nuo Venture Capital and Shunwei Capital;
• In October, 2017, the company obtained the financing of RMB 150 million in Series B, and the investors were Hua Nuo Venture Capital, Fosun Ruizheng Capital and Shunwei Capital;
• In April, 2016, the company obtained financing of RMB 2 million from Angel Wheel, and the investor was Hua Nuo Venture Capital.

Shanghai Dianfei Technology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Zuoyu Capital and Jinkun Capital.

Zhejiang Konghui Automobile Technology Co., Ltd. received 300 million yuan in Series C financing.
It is jointly invested by Chendao Capital, Suikai Investment, Harvest Capital, CGNPC Investment, SDIC Investment Promotion and CMB International Capital.

Tanwei Technology (Beijing) Co., Ltd. obtained strategic investment financing.
It is jointly invested by Xiaomi Group, Jimu Growth and Xuchuang Technology.

Shanghai Shijia Technology Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
It is jointly invested by Kexing Kechuang Investment, Jianmu Investment, Nuoyan Capital and Qiaoqiao Capital.

• In December, 2022, the company obtained the Pre-A round of RMB 20 million financing, and the investors were Ivy Capital and Fupu Investment.

Beijing Anlihua Automobile Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Jinsha River Capital, Marble Global Capital, Chizi Fund and Yushi Capital.

Yingxue Automotive Technology (Changshu) Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by McGemitt.

Government application

Wuxi Chengfeng Aviation Engineering Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
Invested by Jinpu.

Intelligent hardware

Sichuan Zhongjiu Daguang Technology Co., Ltd. received several hundred million yuan in Series B financing.
It is jointly invested by National integration of defense and civilian technologies Industrial Investment Fund, Sichuan integration of defense and civilian technologies Fund, CSSC Capital, Jingjiawei and Changguanghuaxin.

Juxing Technology (Shenzhen) Co., Ltd. was awarded the C-round financing of billion yuan.
It is jointly invested by Anhui Industrial Upgrading Fund, Tongling State Control and Tongling Dajiang.

• In July 2022, the company received RMB 20 million in B+ round financing, and the investor was Fengnian Capital;
• In May 2020, the company obtained A+ round of tens of millions of dollars in financing, and the investors were sequoia capital china, Zhencheng Investment, Zhenge Fund, Mingshi Capital, PKSHA SPARX Algorithm Fund, Chuangyin Capital and Bai Ze Capital (financial advisor);
• In November 2018, the company received RMB 20 million in Pre-A financing, and the investor was Mingshi Capital.

Beijing Tianbing Technology Co., Ltd. received several hundred million yuan in Series C financing.
It is jointly invested by Boyu Investment, CICC Capital and Youshan Capital.

• In December, 2020, the company received RMB 100 million in A+ round financing, and the investors were Guoke Investment and Lushi Investment.

Beijing Juntian Aerospace Technology Co., Ltd. won the Pre-A round of financing of billion yuan.
It is jointly invested by Minyin International, Sunflower Investment and Yuze Capital.

Shenzhen Qianhaida Lu Technology Co., Ltd. received 1 billion yuan in Series C financing.
It is jointly invested by Knowledge City Group, Shanghai Guosheng Investment Group and Shui Mu Chunjin.

• In April 2021, the company received RMB 1 billion in B+ round financing, and the investors were Guosheng Group and Shanghai Chengtou;
• In May 2016, the company received 205 million RMB financing from the seed round, and the investors were SoftBank capital Softbank Overseas, Walden International Investment and Foxconn.

Shanghai youruipu semiconductor equipment co., ltd won tens of millions of yuan in series a financing.
It is jointly invested by Cornerstone Capital, Hunpu Investment, Zhongnan Venture Capital, Honghu Investment, Xinghe Capital, Hangzhou Menghe and Jingning Lingan.

Shanghai Denglin Technology Co., Ltd. won the C round of financing.
Invested by China Net.

Shenzhen Guoweixin Technology Co., Ltd. received hundreds of millions of angel round financing.
It is jointly invested by Anxin Ganhong, Lifeng Investment, Yashang Capital and Bugu Tianque Investment.

Shanghai Tuyang Information Technology Co., Ltd. won the C+ round of financing.
It is jointly invested by Shanghai Guxin Investment Holding Co., Ltd. and Roy.

• In April 2016, the company received RMB 15 million in Pre-A financing;
• In July 2015, the company obtained financing of RMB 2 million from Angel Wheel, and the investor was PreAngel；;
• In January 2015, the company received RMB 4 million in financing from the seed round.

Xinjude Technology (Anhui) Co., Ltd. was granted angel round financing.
It is jointly invested by SMIC Juyuan, Shanghai Zishi, Xi ‘an Tianqi and Tianshui Jiusheng.

Lingdong Technology (Beijing) Co., Ltd. received 200 million yuan of C+ round financing.
It is jointly invested by Anhui State-controlled Investment, Hefei Gaotou and Hefei Investment Capital.

• In March, 2021, the company obtained the financing of RMB 250 million in Series C, and the investors were Dinghui Investment, Zhong Ding Capital, Dehou Fund Management, AA Investment and Zhongguancun Development Group.
• In April 2020, the company received RMB 100 million in B+ round financing, and the investor was China Merchants Capital;
• In August 2019, the company received RMB 20 million in B+ round financing, and the investor was Longhu Capital;
• In January 2018, the company received a round of financing of $10 million;
• In February, 2016, the company received a round of financing of RMB 20 million, with the investors being CDH Investment and Zhong Ding Venture Capital.

Nanjing Yingruichuang Electronic Technology Co., Ltd. received 500 million yuan in Series D financing.
It is jointly invested by mixed reform fund, Geely Holding, Guangzhou Automobile Capital, State Automobile Investment and Chendao Capital.

• In December, 2020, the company received a $20 million financing from C+ round, and the investor was Baolong Technology.

Jilin Qiushi Spectrum Data Technology Co., Ltd. won tens of millions of A+ rounds of financing.
It is jointly invested by Zhongke Chuangxing, SMIC Juyuan and Changxing Fund.

Suzhou Maike Xinna Intelligent Technology Co., Ltd. received tens of millions of angel round financing.
Invested by Oriental Fuhai.

Chengdu Shansiwei Technology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Jingwei Venture Capital, Chongyuan Naxing, Leli Capital and Huimei Capital.

Shenzhen Yugong Technology Co., Ltd. received nearly 10 million yuan in Pre-A round of financing.

Shenzhen Ruilaibo Microelectronics Co., Ltd. received 5 million yuan angel round financing.
It is jointly invested by Huasheng Renhe and Lanhai Zhongli Capital.

Guangbenji Technology (Suzhou) Co., Ltd. received angel round financing of over 50 million yuan.
It is jointly invested by Fengrui Capital, Xiaomiao Langcheng and Qiji Chuangtan.

Beijing Zhige Technology Co., Ltd. won the Pre-B round of financing of billion yuan.
It is jointly invested by Huatai Zijin, Lingyuan Kechuang, Wansheng Foundation Investment and Fangguang Capital.

• In March, 2021, the company received a round of financing of RMB 20 million, and the investors were Juyuan Capital-SMIC Juyuan, Fangguang Capital and Qingkong Ginkgo Venture Capital;
• In July 2020, the company obtained a strategic investment of RMB 20 million, and the investor was Qingkong Ginkgo Venture Capital and Enlightenment Star.

Xinbaite Microelectronics (Wuxi) Co., Ltd. received nearly 100 million yuan in Series A financing.
It is invested by Long Ding and invested by Huizhou.

Singularity Proximity Technology (Shanghai) Co., Ltd. was awarded Series A financing.
Invested by Alibaba.

• In September, 2022, the company obtained RMB financing of 100 million yuan from Angel Wheel, and the investors were Joy Capital, Jingwei Venture Capital and Huaying Capital.

Daqin Digital Energy Technology Co., Ltd. received billions of dollars in Series C financing.
It is jointly invested by CICC Capital, L Catterton, Jinqiu Fund, Shenqi Capital and Artemisia annua Capital.

Shenzhen Beijixin Microelectronics Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
Invested by Ruijiang Fund.

Zhizhen Storage (Beijing) Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
Joint investment by Zhucheng Capital, China Net Investment and Jingpeng Investment.

Saijing Asia-Pacific Semiconductor Technology (Zhejiang) Co., Ltd. received 160 million yuan in Series A financing.
It is jointly invested by Tianjin Anjing Enterprise Management Consulting Partnership, Wuxi Riverbed Runyu Venture Capital Partnership, Wuxi Riverbed Haoyu Venture Capital Partnership and Suzhou Yahe Xingheng Venture Capital Partnership.

Suzhou Heguang Tongyao Intelligent Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
Jointly invested by Jingwei Venture Capital and Xianfeng K2VC.

Beijing Hanwei Chuangxin Electronic Technology Co., Ltd. received 80 million yuan in Series A financing.
It is jointly invested by China Merchants Capital, Sheng ‘ang Investment, Ivy Capital, Gaorong Capital and Kuaichuangying Venture Capital.

Shenzhen Bubu Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Guangyuan Capital, Shenqi Capital, Wuyuan Capital, Rice Venture Capital, XBOTPARK Fund, Brizan Ventures and Zhixing No.1..

Shenzhen Quanxing Technology Co., Ltd. was financed by Angel Wheel.
You Lihe Kechuang invested.

Qingdao Benyuan Microelectronics Co., Ltd. won the B+ round of financing.
Jointly invested by Jiangxia Green Fund and China Innovation Fund.

Hefei Haitu Microelectronics Co., Ltd. received several hundred million yuan of Pre-B financing.
It is jointly invested by Anhui Tietou, Hefei Jiantou Gaotou, Hefei Production and Investment Group, Anhui Cultural Industry Investment Private Equity Fund, Guoyuan Fund and Binhu Science and Technology Venture Capital.

Shanghai Yishi Intelligent Technology Co., Ltd. received 10 million yuan angel round financing.
It is jointly invested by Xinwei Capital, Haoyang Venture Capital, Institute of Micro Technology and Lingang Group.

Shenzhen Dashi Future Technology Co., Ltd. was awarded the financing of 10 million yuan angel round.
It is jointly invested by Lanchi Venture Capital, Black Ant Capital and Bee Qiao Capital.

Zhongshan Zhongde Science & Technology Co., Ltd. was granted financing of 10 million yuan angel round.
Joint investment by Zhihui Chuangfu and Wangzhong Investment.

Hongxin Gas (Shanghai) Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Qisheng Capital and Shenwan Investment Fund.

Hubei Jiuen Intelligent Technology Co., Ltd. received 50 million yuan in Series A financing.
It is jointly invested by Hubei Science and Technology Investment Group and Guoyi Investment.

Lingxin (Chongqing) New Energy Co., Ltd. was financed by Angel Wheel.
Invested by China Merchants Capital.

Suzhou Yuanxing Zhizao Technology Co., Ltd. received tens of millions of angel round financing.
It is jointly invested by Xianfeng Qiyun, Shangshi Capital and Changan Private Capital.

Shenzhen Boer Zhizao Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Invested by Haolan Capital.

Xinling Semiconductor (Suzhou) Co., Ltd. was awarded Series A financing.
It is jointly invested by Core Kinetic Energy Investment, Zhangjiang Ketou, Su Gaoxin Jinkong and Ruiling Capital.

Pasini Perception Technology (Shenzhen) Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
It is jointly invested by Guangyue Investment and Yingfutaike.

• In December, 2022, the company obtained the Pre-A round of RMB 20 million financing, and the investors were Qifu Capital and Haofang Venture Capital.
• In November, 2021, the company received financing of RMB 2 million from Angel Wheel, and the investor made a great achievement.

Xi ‘an Xiangde Information Technology Co., Ltd. received tens of millions of A+ rounds of financing.
Invested by BV Baidu Venture Capital.

• In September, 2022, the company received a round of financing of RMB 20 million, and the investors were Wa Niu Capital, Xinyi Capital, Ganrong Holdings and Xinhe Capital.

Suzhou xinlu semiconductor co., ltd. won Pre-A round of financing
It is jointly invested by Yuanhe Hope, Haiwang Capital, Xinpengwei and Yuanhe Holdings.

Suzhou Xizhi Technology Co., Ltd. received nearly 100 million yuan in strategic investment and financing.
It is jointly invested by Hua Xu Capital, Jianfa Xinxing Investment, Suna Weixin and Congrong Zhixin.

Fujian Zhongke Guangxin Optoelectronic Technology Co., Ltd. received hundreds of millions of strategic investment and financing.
It is jointly invested by Junlian Capital, Xiamen Jianfa Group and Fosun Group.

Qingtian Hengren Intelligent Technology Co., Ltd. won Pre-A round of financing.
It is jointly invested by Fangfu Venture Capital and Mingde Investment.

Shenzhen Yemu Technology Co., Ltd. received several million yuan of seed round financing.
Invested by ATV Optics.

Core string semiconductor (Suzhou) Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Investment by Renfa.

Hangzhou Ultron Photonics Technology Co., Ltd. received tens of millions of yuan in Series B financing.
It is jointly invested by Dingxing Quantum, Haiyue Venture Capital and Xinghua Dingli.

Common-mode Semiconductor Technology (Suzhou) Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Shun Financing Capital, Haiwang Capital, Hushan Capital, Fengyuan Capital, Wuyuefeng Kechuang, Yuanhe Holdings and Depe Investment.

Shanghai Muyi Robot Technology Co., Ltd. was awarded B+ round financing of over 100 million yuan.
It is jointly invested by CITIC Construction Investment Capital and Xunshang Venture Capital.

Hunan Guoke Ruicheng Electronic Technology Co., Ltd. won the B round of financing.
It is jointly invested by Hunan Hi-tech Venture Capital, CICC Capital and Caixin Financial Holdings.

Moge Microfluidic Technology (Shantou) Co., Ltd. was granted seed round financing.
Invested by Northern Lights Venture Capital.

Arctic Xiongxin Information Technology (Xi ‘an) Co., Ltd. was awarded Series A financing of over 100 million yuan.
Joint investment by Fengnian Capital and Zhengwei Capital.

• In October, 2022, the company obtained financing of+150 million RMB from Angel Wheel, and the investors were Qingdao Runyang, Wei Hao Chuangxin, SMIC Xicheng, iFLYTEK Venture Capital and Cong Weiyi.

Zero Gravity Aircraft Industry (Hefei) Co., Ltd. received nearly 100 million yuan in strategic investment and financing.
Jointly invested by Nanjing Jiaogong, Hefei Angel Fund and Lanchi Venture Capital.

Hunan Lifang New Energy Technology Co., Ltd. received several hundred million B+ rounds of financing.
It is jointly invested by Qianhai Ark, Midland New Materials, Dongying Zhuoyu and Anshi New Energy.

Wuhan Xinbida Microelectronics Co., Ltd. received nearly 100 million yuan of Pre-A financing.
It is jointly invested by Xinwei Capital, Hegao Capital and Jinshajiang United Capital.

Shanghai Chengke Microelectronics Technology Co., Ltd. received 200 million yuan in C+ round financing.
It is jointly invested by Zhongke Chuangxing and Henglu Assets.

Beijing Xingsheng Energy Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Hongtai Fund, Yunhe Capital, Haokun Technology and Suzhou Huahui.

Shenzhen Porphyry Photonics Technology Co., Ltd. was awarded Series A financing.
It is jointly invested by Zhuoyuan Capital, Guosheng Assets, Yuanhe Holdings, Hechuang Zhiyuan, Xinhe Capital, Xinghu Holdings, Hainan Rongteng, Lianzhi Investment, Dongguan Weizhuo, Lizhe Venture Capital and Delin Capital.

Shanghai Anpai Core Research Technology Co., Ltd. received nearly 100 million yuan in Series A financing.
Jointly invested by Tongchuang Weiye, Xiachuang Venture Capital, Yuanchuang Duoying Capital and Yun Qi Capital.

Hechao Gaozhuang (Zhongshan) Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
It is jointly invested by Zhongke Chuangxing, Zhongshan Torch Huaying, Wanlian Guangsheng and Liwan Venture Capital.

Ningbo Yuanxin Optoelectronic Technology Co., Ltd. was awarded over 100 million yuan in Series B financing.
It is jointly invested by Zhongke Chuangxing, Xinyi Capital, Changjiang Innovation, Innolux Angel and Haibang Investment.

Suzhou Zhaoxinchi Intelligent Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Jinyu Maowu and Jiangsu Gaotou Group.

Shanghai Zhaoguan Electronic Technology Co., Ltd. received tens of millions of D round financing.
It is jointly invested by Huashan Capital and Changzhou Government Investment Fund.

• In July 2018, the company received RMB 8 million in Series B financing, and the investors were Star VC and Qianhai Parent Fund.

Nanjing Renxin Technology Co., Ltd. received nearly 100 million yuan of Pre-A+ round financing.
Jointly invested by Huashan Capital and Haiwang Capital.

Aiante Technology (Changzhou) Co., Ltd. won the B+ round of financing of 10 million yuan.
Invested by Qitai Capital.

Guangzhou Monochrome Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Jointly invested by Knowledge City Venture Capital and Qinquan Capital.

Tianjin Xinsen Electronic Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Tianying Capital and Zhengling Holdings.

Zhuanxin Semiconductor (Nanjing) Co., Ltd. received nearly 300 million yuan in Series A financing.
It is jointly invested by Xinyi Capital, Jinpu Investment, Xinyuan Furui, Ningmeng Investment, Yiling Capital and Zhongbo Juli.

Dierborg (Shenzhen) Intelligent Technology Co., Ltd. received tens of millions of angel round financing.
Invested by Lanchi Venture Capital.

Hefei Nanuo Semiconductor Co., Ltd. received tens of millions of yuan in Series A financing.
Jointly invested by Shui Mu Venture Capital and Innolux Angel Fund.

Anhui Aide Future Intelligent Technology Co., Ltd. won tens of millions of yuan in Pre-A round of financing.
Invested by Sky Capital.

Chengdu Yichuang Microelectronics Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Bite Fund, Beijing Integrated Circuit Manufacturing and Equipment Fund, Xinxin Venture Capital and Fengyuan Capital.

Shenzhen Xianshun Technology Co., Ltd. received 10 million yuan angel round financing.
Invested by MOODY.

Hubei Chu Guang 3D Sensing Technology Co., Ltd. received nearly 10 million yuan in angel round financing.
Invested by Fengrui Capital.

Hangzhou Xingchen Dahai Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Zijin Port Capital, Junhe Investment, Titan Heyuan and Tianhai Defense.

Shanghai Tuogong Robot Co., Ltd. won the C round of financing.
Invested by RMB-containing capital.

• In September 2015, the company received financing of RMB 2 million from Angel Wheel, and the investor was Safran Fund.

Shenzhen Sitan Technology Co., Ltd. received 100 million yuan of strategic investment financing.
It is jointly invested by CICC Capital, Safran Investment and wholly-owned subsidiaries of A-share power management chip listed companies.

Guangzhou Yixin Life Science Co., Ltd. received tens of millions of angel round financing.
Jointly invested by Core Aviation Capital and Future Light Cone.

Singular Moore (Shanghai) Integrated Circuit Co., Ltd. won 100 million yuan Pre-A round of financing.
It is jointly invested by Mixed Reform Fund, Zhongguancun Development Sailing Industry Investment Fund, Lirong Yuanchang, Rice Venture Capital, Jinnan Haihe Zhixuan and Junhao Hongshi.

Life service

Shanghai Tianyu Wisdom Pension Service Co., Ltd. won the B round of financing.
Jointly invested by Dahua Venture Capital and Changling Capital.

Weiyuan Synthetic Biotechnology (Beijing) Co., Ltd. received 100 million yuan of Pre-A financing.
It is jointly invested by Shunxi Fund, Beidaihe New District High-tech Industry Fund and Henan Investment Group.

• In August 2023, the company received RMB 20 million in Pre-A+ financing, and the investor was Jingwei Venture Capital.

Guoyuanli (Beijing) Biotechnology Co., Ltd. received tens of millions of yuan in Series A financing.

Beijing Xinghan Internet Co., Ltd. received 180 million yuan of undefined financing.
It is jointly invested by Smart Internet Industry Fund, Qianhai Parent Fund and National integration of defense and civilian technologies Industrial Investment Fund.

Weiyuan Synthetic Biotechnology (Beijing) Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
Invested by Jingwei Venture Capital.

• In July, 2023, the company obtained the Pre-A financing of RMB 100 million, and the investors were Shunxi Fund, Beidaihe New District High-tech Industry Fund and Henan Investment Group.

Kaierzi (Beijing) Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Jinding Capital.

Jiangsu Dingweitai Food Co., Ltd. received tens of millions of Pre-IPO financing.
Invested by Bailian Zhigao Capital.

• In June, 2022, the company obtained nearly RMB 100 million in strategic investment financing, and the investors were Yida Capital and Hongzhang Capital.

Hangzhou Meisu Zaitu Network Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.

Beijing Jiuzhang Yunji Technology Co., Ltd. received 80 million yuan of strategic investment financing.
Invested by Huamin.

• In May, 2021, the company obtained a financing of RMB 300 million in Series C, with the investors being Shangyi Capital, SAIF Partners (), Junzi Capital, LinkedIn Capital, Kexi Capital and Zhiyuan Capital (Yitai Chuangfu) (financial consultant);
• In March 2018, the company received RMB 20 million in round B financing, and the investor was Xianghe Capital;
• In October 2014, the company received financing of RMB 4.5 million from Angel Wheel.

Henan Mulanshan Catering Management Co., Ltd. received millions of angel round financing.
Invested by Naixue Tea.

Shanghai Niaoyuhuaxiang Pet Co., Ltd. received nearly 100 million A+ rounds of financing.
It is jointly invested by Naes Investment and CICC Capital.

• In August, 2022, the company received a round of financing of RMB 20 million, and the investors were CICC Capital and Naes Investment.

tool

Beijing Yihui Information Technology Co., Ltd. received hundreds of millions of C round financing.
It is jointly invested by Nanjing Innovation Investment Group, Long Ding Investment, Lushi Investment, SDIC Investment Promotion and Zijin Science and Technology Innovation.

Granular World (Shanghai) Information Technology Co., Ltd. was awarded RMB 10 million in Series B+ financing.
Invested by BYD.

• In November, 2021, the company obtained the B-round financing of tens of millions of dollars, and the investor was Gaochun Venture Capital;
• In January 2021, the company received a strategic investment of RMB 20 million, and the investor was Hubble Investment.
• In December 2019, the company received A+ round of financing of 20 million US dollars, and the investors were C Capital, Gaochun Capital and Linear Capital;
• In December 2018, the company received a round of financing of RMB 20 million, and the investors were linear capital, door venture capital and linear capital.

Shenzhen Jinmen Finance Technology Co., Ltd. received 100 million yuan of B+ round financing.
Invested by Tencent.

• In March, 2023, the company received a series B financing of RMB 120 million, and the investors were Gaocheng Capital and Ivy League Capital.
• In August 2015, the company obtained an undisclosed US dollar financing in A round, and the investor was Qifu Capital;
• In May 2014, the company obtained financing of RMB 2 million from Angel Wheel.

social contact

Shanghai Jiachi Business Consulting Co., Ltd. received 100 million yuan in Series C financing.
It is jointly invested by Huajing Investment, Zhilian Capital, Wisdom Ark and Kang Orange Investment.

• In June 2019, the company received A+ round of RMB 20 million financing, and the investor was CICC Capital;
• In September, 2016, the company received financing of RMB 5 million from Angel Wheel, and the investor was Sko headhunter.

artificial intelligence

Xi’ an Lingkong Electronic Technology Co., Ltd. won the D+ round of financing.
Invested by Sunrise AXA Capital.

Ningbo New Computing Technology Co., Ltd. won the Pre-A round of financing.
It is jointly invested by Shunwei Capital, Huafang Capital and Sequoia China.

Xiamen Yuanting Information Technology Co., Ltd. won the billion-dollar B+ round of financing.
It is jointly invested by Jianxin Equity and CICC Capital.

• In May, 2022, the company obtained the B round of RMB 100 million financing, and the investor was Dachen Caizhi;
• In November 2019, the company received a round of financing of RMB 100 million, and the investors were CLP JAIC and Xiamen Venture Capital.

Juxing Technology (Shenzhen) Co., Ltd. was awarded the C-round financing of billion yuan.
It is jointly invested by Anhui Industrial Upgrading Fund, Tongling State Control and Tongling Dajiang.

• In July 2022, the company received RMB 20 million in B+ round financing, and the investor was Fengnian Capital;
• In May 2020, the company obtained A+ round of tens of millions of dollars in financing, and the investors were sequoia capital china, Zhencheng Investment, Zhenge Fund, Mingshi Capital, PKSHA SPARX Algorithm Fund, Chuangyin Capital and Bai Ze Capital (financial advisor);
• In November 2018, the company received RMB 20 million in Pre-A financing, and the investor was Mingshi Capital.

Shenzhen Qianhaida Lu Technology Co., Ltd. received 1 billion yuan in Series C financing.
It is jointly invested by Knowledge City Group, Shanghai Guosheng Investment Group and Shui Mu Chunjin.

• In April 2021, the company received RMB 1 billion in B+ round financing, and the investors were Guosheng Group and Shanghai Chengtou;
• In May 2016, the company received 205 million RMB financing from the seed round, and the investors were SoftBank capital Softbank Overseas, Walden International Investment and Foxconn.

Shanghai Denglin Technology Co., Ltd. won the C round of financing.
Invested by China Net.

Shanghai Xingtubite Information Technology Service Co., Ltd. received 15 million yuan in Series A financing.
Invested by guomai culture.

Shanghai Tuyang Information Technology Co., Ltd. won the C+ round of financing.
It is jointly invested by Shanghai Guxin Investment Holding Co., Ltd. and Roy.

• In April 2016, the company received RMB 15 million in Pre-A financing;
• In July 2015, the company obtained financing of RMB 2 million from Angel Wheel, and the investor was PreAngel；;
• In January 2015, the company received RMB 4 million in financing from the seed round.

Xihu Xinchen (Hangzhou) Technology Co., Ltd. was awarded strategic investment financing of over 100 million yuan.
Invested by Tom Cat.

• In March, 2023, the company received a Pre-A round of financing of US$ 2 million, and the investors were Baidu Venture Capital, Cailletet Capital and Xihu Education Foundation.

Guangdong tasker Robot Co., Ltd. was awarded the A+ round of financing.
Invested by the cargo girl.

• In September, 2022, the company received a round of financing of several hundred million yuan, and the investors were Yilian Venture Capital, Zhenge Fund and Zero One Venture Capital.

Chengdu Times Starlight Technology Co., Ltd. received tens of millions of A+ rounds of financing.
Invested by Tianyan Junrun.

Lingdong Technology (Beijing) Co., Ltd. received 200 million yuan of C+ round financing.
It is jointly invested by Anhui State-controlled Investment, Hefei Gaotou and Hefei Investment Capital.

• In March, 2021, the company obtained the financing of RMB 250 million in Series C, and the investors were Dinghui Investment, Zhong Ding Capital, Dehou Fund Management, AA Investment and Zhongguancun Development Group.
• In April 2020, the company received RMB 100 million in B+ round financing, and the investor was China Merchants Capital;
• In August 2019, the company received RMB 20 million in B+ round financing, and the investor was Longhu Capital;
• In January 2018, the company received a round of financing of $10 million;
• In February, 2016, the company received a round of financing of RMB 20 million, with the investors being CDH Investment and Zhong Ding Venture Capital.

Nanjing Beixin Intelligent Technology Co., Ltd. was financed by Angel Wheel.
Invested by Nanjing Innovation Investment Group.

Beijing Tribute to Unknown Technology Co., Ltd. received 10 million yuan angel round financing.
It is jointly invested by Alibaba, Niou Capital, Taiya Investment, Hefei Beicheng Jiantou and Taiyue Wutong Capital.

Shenzhen Huayang Yuguang Auto Parts Co., Ltd. received tens of millions of Pre-A rounds of financing.
Invested by Guiyang Venture Capital.

Yunshuo IOT Technology (Shanghai) Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Qifu Capital.

• In February, 2021, the company obtained the Pre-A round of 10 million RMB financing, and the investor was Honghu Capital；;
• In May, 2020, the company obtained a strategic investment of RMB 30 million, and the investors were CRB Antriebstechnik GmbH and Huoyan Investment.

Rice Robotics received 7 million yuan in Pre-A round of financing.
It is jointly invested by Sun Hung Kai Properties, Cyberport Hong Kong, Alibaba Entrepreneur Fund, Soul Capital Limited and Audacy Ventures.

Shanghai Wenjie Exploration Technology Development Co., Ltd. received 10 million yuan angel round financing.
Jointly invested by Jinqiu Fund and Creation Partner CCV.

Beijing Zhipu Huazhang Technology Co., Ltd. received hundreds of millions of B+ rounds of financing.
Invested by the Strategic Investment Department of Meituan.

• In September, 2021, the company obtained a round of financing of several hundred million RMB, and the investors were Dachen Caizhi, Huakong Fund, Door Venture Capital, Turing Venture Capital, Lingyunguang Technology, Beijing Dafan, Tongzhi Investment, Zaozhuang Tongzhi and Rongpin Investment.

Action Yuan (Shanghai) Technology Co., Ltd. received 120 million yuan in Series A financing.

Guanglun Intelligent (Beijing) Technology Co., Ltd. received tens of millions of angel wheel+financing.
It is jointly invested by SEE Fund, Variable Capital, Miracle Chuangtan and Chentao Capital.

Shenzhen Bell Information Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Junlian Capital and Jinshajiang United Capital.

Shanghai Ditu Information Technology Co., Ltd. was awarded Pre-A round financing of over 10 million yuan.
Invested by Xinzhi.

Beijing Ling ‘ao Technology Co., Ltd. received several million yuan of seed round financing.
It is jointly invested by Jingya Capital and Plug and Play.

Hangzhou Li Wei Keke Technology Co., Ltd. received tens of millions of A round financing.
Invested by Chinese capital.

Suzhou Washeng Technology Co., Ltd. was awarded a billion-dollar C round of financing.
Invested by Haochen Capital.

• In July, 2022, the company obtained a series B financing of RMB 100 million. The investors were Jinpu Investment, Yuanwang Capital, GGV ggv capital, Haochen Capital and Wanshi Capital (financial advisor);
• In January, 2021, the company obtained a round of financing of RMB 100 million, with GGV ggv capital, Zhong Ding Capital and Yuanwang Capital as investors.

Hunan Quanyu Industrial Equipment Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Delian Capital and Shunxi Fund.

Jindie Shikong (Hangzhou) Technology Co., Ltd. received several hundred million yuan in Series A financing.
It is jointly invested by Lenovo Venture Capital, Junlian Capital, Shunxi Fund, Jingwei Venture Capital, Yaotu Capital, Wanwu Capital, Zhenge Fund, Broad Sky Venture Capital and Fun Joint Venture Capital.

Shenzhen Yuanlian Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Huaying Capital and Huaxun Assets.

Jiayi Xiaoan (Shanghai) Robot Technology Co., Ltd. received nearly 100 million yuan in Series A financing.
Invested by Changsha Qunxin.

• In September, 2021, the company received RMB 20 million in Pre-A financing, and the investor was Lansi Technology.

Beijing Aishi Technology Co., Ltd. received tens of millions of angel round financing.

Shenzhen Laiyufei Intelligent Technology Co., Ltd. was awarded Pre-A round financing of over 10 million yuan.
Invested by MAX Innovation Capital.

Beijing Tiandi Yige Technology Co., Ltd. received nearly 40 million yuan in Series B financing.
Invested by Canghai Capital.

Shanghai Aosha Intelligent Technology Co., Ltd. was awarded Series A financing.
Invested by Guoyi Capital.

• In February 2019, the company obtained financing of RMB 2 million from Angel Wheel, and the investors were Mingshi Capital, Xianfeng Evergreen and Mingshi Capital.

Pasini Perception Technology (Shenzhen) Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
It is jointly invested by Guangyue Investment and Yingfutaike.

• In December, 2022, the company obtained the Pre-A round of RMB 20 million financing, and the investors were Qifu Capital and Haofang Venture Capital.
• In November, 2021, the company received financing of RMB 2 million from Angel Wheel, and the investor made a great achievement.

Beijing Shengshu Technology Co., Ltd. received tens of millions of angel round+financing.
Invested by Jinqiu Fund.

• In June, 2023, the company obtained financing of nearly RMB 100 million from Angel Wheel, and the investors were Ant Group, BV Baidu Venture Capital and Zhuoyuan Capital.

Nanjing Hanhua Fluid Technology Co., Ltd. was awarded Series A financing.
Invested by Taiya Capital.

Zhongke Jiahe (Beijing) Technology Co., Ltd. received tens of millions of seed round financing.
It is jointly invested by BV Baidu Venture Capital, Chenshan Capital, Lushi Investment, Qiji Chuangtan, Cambrian, Tianchuang Capital and Photosynthetic Fund.

Shanghai Muyi Robot Technology Co., Ltd. was awarded B+ round financing of over 100 million yuan.
It is jointly invested by CITIC Construction Investment Capital and Xunshang Venture Capital.

Jacobi (Guangzhou) Robot Co., Ltd. was granted seed round financing.
Invested by Lu Qi.

Shenzhen Bi ‘an Mind Technology Co., Ltd. was granted angel round financing.
Invested by Zhongke Angel.

Frequency Exploration Intelligent Technology Jiangsu Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Yonghua Investment and Changzhou High-tech Investment.

Shenzhen Tuzhan Intelligent Technology Co., Ltd. was awarded D+ round financing of over 100 million yuan.
Newly invested by Nanshan War.

Suzhou Peixin Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Lilly Asia Fund, Suzhou Park Science and Technology Innovation Fund and Jiasheng Venture Capital.

Granular World (Shanghai) Information Technology Co., Ltd. was awarded RMB 10 million in Series B+ financing.
Invested by BYD.

• In November, 2021, the company obtained the B-round financing of tens of millions of dollars, and the investor was Gaochun Venture Capital;
• In January 2021, the company received a strategic investment of RMB 20 million, and the investor was Hubble Investment.
• In December 2019, the company received A+ round of financing of 20 million US dollars, and the investors were C Capital, Gaochun Capital and Linear Capital;
• In December 2018, the company received a round of financing of RMB 20 million, and the investors were linear capital, door venture capital and linear capital.

Harbin Weilan Innovation & Technology Co., Ltd. was awarded Series A financing of over 100 million yuan.
Invested by the state-owned market-oriented fund.

Shanghai Zhaoguan Electronic Technology Co., Ltd. received tens of millions of D round financing.
It is jointly invested by Huashan Capital and Changzhou Government Investment Fund.

• In July 2018, the company received RMB 8 million in Series B financing, and the investors were Star VC and Qianhai Parent Fund.

Beijing Guixin Technology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Qingliu Capital, Binfu Capital and Sanqi Mutual Entertainment Venture Capital.

Beijing Cyberlink Technology Co., Ltd. won the financing of 10 million yuan angel wheel+.
It is jointly invested by Qihai Capital and Shenzhen Venture Capital Sotheby’s Fund.

Dongguan Benmo Technology Co., Ltd. won the A+ round of financing of 10 million yuan.
Joint investment by Liwan Capital and Jianyuan Investment.

• In October, 2022, the company received a round of financing of RMB 20 million, and the investors were Songhe Capital, Lenovo Venture Capital, Yifeng Capital, Wuyuan Capital and Qiji Chuangtan.

Beijing Hollister Technology Co., Ltd. received several hundred million yuan in Series B financing.
It is jointly invested by China’s state-owned capital venture capital fund, Minmetals Venture Capital, Zhengyu Investment and unlimited fund SEE Fund.

Times Emergence Information Technology (Nanjing) Co., Ltd. received nearly 100 million yuan in Series B financing.
It is jointly invested by DCM, Jinshajiang Venture Capital and Huashan Capital.

Zhonghao Xinying (Hangzhou) Technology Co., Ltd. received tens of millions of Pre-B rounds of financing.
Invested by Huaxia Hengtian.

Beijing Jiuzhang Yunji Technology Co., Ltd. received 80 million yuan of strategic investment financing.
Invested by Huamin.

• In May, 2021, the company obtained a financing of RMB 300 million in Series C, with the investors being Shangyi Capital, SAIF Partners (), Junzi Capital, LinkedIn Capital, Kexi Capital and Zhiyuan Capital (Yitai Chuangfu) (financial consultant);
• In March 2018, the company received RMB 20 million in round B financing, and the investor was Xianghe Capital;
• In October 2014, the company received financing of RMB 4.5 million from Angel Wheel.

Beijing Kaiwang Data Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Yasheng Investment and Qingzhi Capital.

Core-Computing Integration (Xi ‘an) Technology Co., Ltd. was awarded a strategic investment financing of 10 million yuan.
It is jointly invested by Huizhi China and Manshi Capital.

• In April, 2023, the company obtained RMB financing of 10 million yuan from Angel Wheel, and the investor was Peter Li.

Hangzhou Guiyi Intelligent Technology Co., Ltd. received tens of millions of strategic investment and financing.
It is jointly invested by Leo and Weiying Technology.

Dai Meng (Shenzhen) Robot Technology Co., Ltd. received tens of millions of angel round financing.
Invested by Kunzhong Capital.

Hangzhou Digital Chain Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
It is jointly invested by Zhengfang Assets, Taiheng Investment, Linping Guotou and Hangzhou Dunjun Assets.

Beijing Aocheng Intelligent Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Fanzhuo Capital.

Hunan Gugong Robot Co., Ltd. received millions of angel round financing.
Invested by Chen Zhongping.

Beijing Qingsheng Zhikong Technology Co., Ltd. was awarded a seed round of 10 million yuan.
Jointly invested by Linge Venture Capital and Galileo Capital.

Nanjing Hanhai Fuxi Defense Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
Invested by Yun Ze Capital.

Bo Yun Jian Ri (Shenzhen) Intelligent Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Iflytek.

go shopping

Hangzhou Kechang Technology Consulting Co., Ltd. was awarded strategic investment financing.
Invested by Tiger Medicine.

• In April 2016, the company received a round of financing of RMB 20 million, and the investor shared the investment;
• In October 2015, the company received RMB 20 million in Pre-A financing, and the investor was Shanghai Dezhihe Investment.

Shanghai Yule Network Technology Co., Ltd. won the B+ round of financing.
Invested by xiaohongshu.

Aiante Technology (Changzhou) Co., Ltd. won the B+ round of financing of 10 million yuan.
Invested by Qitai Capital.

Exercise and fitness

Wuxi Xingwei Technology Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Yaotu Capital, Ivy Capital and Beiyang Haitang Fund.

travel

Guangzhou Huideng Information Technology Co., Ltd. received tens of millions of yuan in Series B financing.
By becoming a capital, Mingyu Venture Capital jointly invested.

finance

Shanghai Xunhui Information Technology Co., Ltd. won the D+ round of financing.
It is jointly invested by Peak XV Partners, Prosperity7 Ventures and Softbank Asia.

• In July 2017, the company received a round of financing of RMB 20 million, and the investor was Huachuang Capital;
• In March 2016, the company obtained the A round of undisclosed US dollar financing, and the investor was Xiaochang Shui Mu Investment (Tang Binsen);
• In December 2015, the company obtained financing of RMB 2 million from Angel Wheel, and the investor was Xianfeng Changqing (Xianfeng Huaxing).

Drip irrigation management consulting (Hainan) Co., Ltd. received 458 million yuan in Series C financing.

Shenzhen Jinmen Finance Technology Co., Ltd. received 100 million yuan of B+ round financing.
Invested by Tencent.

• In March, 2023, the company received a series B financing of RMB 120 million, and the investors were Gaocheng Capital and Ivy League Capital.
• In August 2015, the company obtained an undisclosed US dollar financing in A round, and the investor was Qifu Capital;
• In May 2014, the company obtained financing of RMB 2 million from Angel Wheel.

Elephant Huiyun Information Technology Co., Ltd. received 100 million yuan in Series C financing.
It is jointly invested by Guizhou Innovation Empowerment Big Data Investment Fund and Guiyang Guanshanhu Modern Service Industry Development Venture Capital Fund.

self-driving

Beijing Kaiwang Data Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Yasheng Investment and Qingzhi Capital.

agriculture

Shanghai Zuo ‘an Xinhui Electronic Technology Co., Ltd. was awarded strategic investment financing.
Invested by Zhiyuan Internet.

Yimu Technology (Beijing) Co., Ltd. received tens of millions of angel round financing.
Invested by linear capital.

Qingdao Qingyuan Crop Science Co., Ltd. was awarded Series A financing.
It is jointly invested by Qianhai Parent Fund and Herbal Capital.

Shijiazhuang Boruidi Biotechnology Co., Ltd. received tens of millions of yuan in strategic investment financing.
It is jointly invested by Daotong Investment, Chende Capital, Haochen Capital and Junhua Investment.

• In February, 2023, the company obtained A+ round financing of over RMB 100 million, and the investors were Alibaba, Haochen Capital, Wanwu Capital, Yunzhi Capital and Jihui Capital.

Shiji Biotechnology Co., Ltd. received 400 million yuan of strategic investment financing.
It is jointly invested by CICC Capital and Anhui Guokong Group.

blockchain

Shanghai Shaotang Culture Technology Co., Ltd. received 5 million yuan angel round financing.
Invested by Zhongzhou Holdings.

Yuanyi Technology (Beijing) Co., Ltd. received millions of angel round financing.

big data

Beijing Fule Technology Co., Ltd. was awarded strategic investment financing.
Invested by the electricity department.

• In August, 2020, the company obtained a round of financing of RMB 20 million in B, and the investors were Songhe Capital and Cornerstone Capital.

Shanghai Zero Number Technology Co., Ltd. received tens of millions of B+ rounds of financing.
Invested by Guoxin Zhongshu.

Tianfu Gaofen (Beijing) Technology Co., Ltd. won the Pre-A round of financing of 10 million yuan.
Invested by Hongfu Assets.

other

Shenzhen Yilanke Electric Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Joint investment by Times Bole, Kunzhong Capital and Gongqing Jingcheng.

Zhuhai Guangyu Technology Co., Ltd. was financed by Angel Wheel.
Invested by BASF Venture Capital.

Guangdong Espoo Optoelectronic Technology Co., Ltd. was awarded Series A financing.
It is jointly invested by Shengkun Investment, Zhuoyuan Capital and Guohong Investment.

Shenzhen Weifang Energy Technology Co., Ltd. received several hundred million yuan of Pre-B round financing.
Invested by Xinte Electric.

Shanghai Yuangexin Material Technology Co., Ltd. won Pre-A round of financing.
Invested by Yonghua.

Shanghai Cairi Energy Technology Co., Ltd. won the C round of financing.
It is jointly invested by Industrial Fulian and Kaishi Investment.

Xiamen Haichen Energy Storage Technology Co., Ltd. received more than 4.5 billion yuan in Series C financing.
Invested by Jin Ruihe.

Jiaxin semiconductor equipment technology co., ltd. won Pre-A round of financing
Invested by BYD.

Ningbo Zhongke Hydrogen Membrane Technology Co., Ltd. received tens of millions of angel round financing.
It is jointly invested by Linge Venture Capital, State Power Investment, Huajin Capital, Yinan Capital, Fanchuang Capital and Zhenhai Investment.

Shenzhen Weibo Chire Technology Co., Ltd. received tens of millions of A+ rounds of financing.
Invested by Huarui Capital.

Aihefa Industrial Transmission Technology (Guangdong) Co., Ltd. received tens of millions of angel round financing.
It is jointly invested by Shenzhen Hi-tech Investment and Jingtai Huafu.

Zhengtai Xinneng Technology Co., Ltd. received 2 billion yuan in Series C financing.
It is jointly invested by Chaoxi Capital, Changjiang Industrial Fund, Bank of Communications Investment, China Life Capital, CICC Capital, CITIC Construction Investment Capital, Walden International and Yuexiu Investment.

Botai Automation Technology (Shanghai) Co., Ltd. received 30 million yuan of seed round financing.
Joint investment by Zhengxuan Investment and Yaotu Capital.

Beijing Micro-motion Space-time Technology Co., Ltd. received tens of millions of yuan in strategic investment and financing.
It is jointly invested by Century Capital, Yonggui Fund and Beijing Xinhangcheng.

• In December, 2021, the company received RMB 10 million financing from Angel Wheel, and the investors were Zhongke Chuangxing, Qiji Chuangtan and Venture Dark Horse Fund.

Ningbo Liansheng Zhuochuang New Energy Technology Co., Ltd. won the C round of financing.
It is jointly invested by Caive Fund and source capital.

Wuhan Clene Technology Co., Ltd. was granted angel round financing.
Invested by Tongchuang Weiye.

Hangzhou Shen Shi Energy Saving Technology Co., Ltd. was awarded strategic investment financing.
It is jointly invested by Sinochem Capital, Zhejiang Energy Group and Zhike Investment.

Suzhou Xuxin Intelligent Technology Co., Ltd. won tens of millions of yuan in Pre-A round of financing.

Hongxin Gas (Shanghai) Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Qisheng Capital and Shenwan Investment Fund.

Wuhan Newforth Biotechnology Co., Ltd. received 700 million yuan of C+ round financing.
It is jointly invested by CMB International Capital, Optics Valley Financial Control, Wuhan Hi-Tech, Optics Valley Health, Guangzhou Financial Control, SDIC Investment Promotion, Paradise Silicon Valley and Yangtze River Investment.

• In November, 2021, the company obtained the financing of RMB 400 million in Series C, and the investors were China Investment, Sequoia Capital China, Sunshine Insurance and CMB International.
• In February, 2021, the company received a series B financing of RMB 400 million, with the investors being Huaxin Investment, Yuanfang Capital, Yuanhe Holdings, Sequoia Capital China, Northern Lights Venture Capital, Guofeng Capital and Huiyuan Capital;
• In April, 2020, the company obtained a series A financing of RMB 130 million, and the investors were sequoia capital china, Fuxing Future Capital and Northern Lights Venture Capital.

Wuhan Qina New Energy Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
It is jointly invested by Guohua Investment, Guangfa Shunde, Dingxiang Capital and Kaixian Capital.

Tianjin Jingyi Precision Measurement Technology Co., Ltd. received tens of millions of A round financing.
It is jointly invested by Gaochun Venture Capital, Black Oak Capital and Haihe New Kinetic Energy Fund.

Shenzhen Jiana Energy Technology Co., Ltd. was awarded Series A financing.
Joint investment by Chunhua Capital and Shunwei Capital.

Wuhan Xiangyin Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Zhengxuan Investment, Shun Financing Capital and Huagong Ruiyuan.

Jiangsu Yadian Technology Co., Ltd. was awarded Series A financing.
It is jointly invested by Jianxin International Trade, Jiangsu Hi-Tech Industrial Investment, Yunhui Capital and Zhongtian Huifu.

Huangshan Jin Rui Tai Technology Co., Ltd. received tens of millions of yuan in Series B financing.
Invested by Yuanning.

Hunan Shunhua Lithium Industry Co., Ltd. received nearly 100 million yuan in Pre-B round financing.
It is jointly invested by China Mining Resources, Xiongtao, Laishun Venture Capital, Shengshi Juxing Investment and Aotu Venture Capital.

Shanghai Lizhao Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by SMIC Juyuan, Monolith Lisi Capital and Lingang Venture Capital.

Yuanneng Technology (Xiamen) Co., Ltd. received tens of millions of Pre-A rounds of financing.
It is jointly invested by Founder Hesheng Investment, Xiamen Tungsten Jiatai, Xiamen Hi-tech Investment and Hefang Capital.

Shenzhen Colorful Xiangyun Information Technology Co., Ltd. received nearly 100 million yuan in Series B financing.
It is jointly invested by Qifu Capital, Venture Workshop, Xianfeng K2VC, Zhengxuan Investment and Taiya Investment.

Nayuan New Materials Technology (Wuxi) Co., Ltd. received tens of millions of angel round financing.
It is jointly invested by Jinjue Capital and Xintou Angel Fund.

Hunan Lanyue Electromechanical Technology Co., Ltd. won Pre-A round of financing of over 100 million yuan.
Invested by the parent fund of the National SME Development Fund.

Shenzhen Pangu Naxiang New Energy Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Jointly invested by Tin Venture Capital and Wuxi Municipal Public Utilities Group.

• In June, 2023, the company obtained financing of RMB 20 million from Angel Wheel, and the investors were Xinzhoubang, Gemei, Jingshan Light Machine, Xingyuan Materials and Zhengtong Electronics.

Beijing Jingjing Interactive Technology Co., Ltd. won the seed round financing of 10 million yuan.
Invested by Hangzhou Yuhao.

Jiangsu Xuhai Optoelectronic Technology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Hongsheng Capital, Chunchao Fund and Renxian Capital.

Xiamen Longchuan Junan New Energy Co., Ltd. was financed by Angel Wheel.
Invested by Quanzhou Jinkong Group.

Naweixingke (Beijing) Technology Co., Ltd. received tens of millions of angel round+financing.
It is jointly invested by Qingkong Jinxin Capital and Langmafeng Venture Capital.

Guoke Lingxian New Materials (Changzhou) Co., Ltd. was awarded the financing of 10 million yuan angel round.
It is jointly invested by Linge Venture Capital, Gobi Venture Capital, Fanchuang Capital and Changzhou Weichi.

Ningbo Yuntu Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Invested by Woyan Capital.

Saiyuan Biotechnology (Hangzhou) Co., Ltd. received tens of millions of yuan in Series C financing.
It is jointly invested by Zijin Port Capital and Yuhang Guotou Group.

• In February, 2022, the company obtained nearly RMB 100 million in round B financing, and the investors were Jifeng Capital and Kunlun Capital.
• In July 2021, the company received a strategic investment of RMB 20 million, and the investor was Kunlun Capital.

Beijing North Yiheng Technology Co., Ltd. received 170 million yuan in Series B financing.
It is jointly invested by SDIC Venture, Novartis Capital and Wang Minwen.

Suzhou Zhonghui Laser Technology Co., Ltd. won the A+ round of financing.
It is jointly invested by Zaishi Capital, Dachen Venture Capital and Northern Lights Venture Capital.

Suzhou Site Intelligent Technology Co., Ltd. received tens of millions of A+ rounds of financing.
Invested by Yuanhe Holdings.

Beijing Yimei Xinchuang Technology Co., Ltd. won the D round of financing of billion yuan.
It is jointly invested by Yiwu Investment Fund and Xinxin Assets.

Nanjing Huayitai Electronic Technology Co., Ltd. was awarded Series B financing.
Venture capital invested by small and medium-sized enterprises in Huzhou.

home

Shenzhen Lingwu Life Technology Co., Ltd. received 5 million yuan angel round financing.

Enterprise application

Beilian Zhuguan Technology (Zhejiang) Co., Ltd. received 50 million yuan angel round financing.
It is jointly invested by Yuanjing Capital, Sequoia China Seed Fund and Zhouxuan Equity Investment.

Xiamen Yuanting Information Technology Co., Ltd. won the billion-dollar B+ round of financing.
It is jointly invested by Jianxin Equity and CICC Capital.

• In May, 2022, the company obtained the B round of RMB 100 million financing, and the investor was Dachen Caizhi;
• In November 2019, the company received a round of financing of RMB 100 million, and the investors were CLP JAIC and Xiamen Venture Capital.

Shenzhen Qianhaida Lu Technology Co., Ltd. received 1 billion yuan in Series C financing.
It is jointly invested by Knowledge City Group, Shanghai Guosheng Investment Group and Shui Mu Chunjin.

• In April 2021, the company received RMB 1 billion in B+ round financing, and the investors were Guosheng Group and Shanghai Chengtou;
• In May 2016, the company received 205 million RMB financing from the seed round, and the investors were SoftBank capital Softbank Overseas, Walden International Investment and Foxconn.

Shanghai Jiachi Business Consulting Co., Ltd. received 100 million yuan in Series C financing.
It is jointly invested by Huajing Investment, Zhilian Capital, Wisdom Ark and Kang Orange Investment.

• In June 2019, the company received A+ round of RMB 20 million financing, and the investor was CICC Capital;
• In September, 2016, the company received financing of RMB 5 million from Angel Wheel, and the investor was Sko headhunter.

Hefei Hoyin Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Qi An Chuan Development Fund.

Beijing Fule Technology Co., Ltd. was awarded strategic investment financing.
Invested by the electricity department.

• In August, 2020, the company obtained a round of financing of RMB 20 million in B, and the investors were Songhe Capital and Cornerstone Capital.

Shanghai Tuyang Information Technology Co., Ltd. won the C+ round of financing.
It is jointly invested by Shanghai Guxin Investment Holding Co., Ltd. and Roy.

• In April 2016, the company received RMB 15 million in Pre-A financing;
• In July 2015, the company obtained financing of RMB 2 million from Angel Wheel, and the investor was PreAngel；;
• In January 2015, the company received RMB 4 million in financing from the seed round.

Zhongshan Huazhen Software Technology Co., Ltd. won the Pre-A round of financing of 10 million yuan.
It is jointly invested by Huasuanbang Group, Shunding IOT, Huanxu Real Estate and Huajia Investment.

Lingdong Technology (Beijing) Co., Ltd. received 200 million yuan of C+ round financing.
It is jointly invested by Anhui State-controlled Investment, Hefei Gaotou and Hefei Investment Capital.

• In March, 2021, the company obtained the financing of RMB 250 million in Series C, and the investors were Dinghui Investment, Zhong Ding Capital, Dehou Fund Management, AA Investment and Zhongguancun Development Group.
• In April 2020, the company received RMB 100 million in B+ round financing, and the investor was China Merchants Capital;
• In August 2019, the company received RMB 20 million in B+ round financing, and the investor was Longhu Capital;
• In January 2018, the company received a round of financing of $10 million;
• In February, 2016, the company received a round of financing of RMB 20 million, with the investors being CDH Investment and Zhong Ding Venture Capital.

Shanghai Zuo ‘an Xinhui Electronic Technology Co., Ltd. was awarded strategic investment financing.
Invested by Zhiyuan Internet.

Shanghai ya’ an technology co., ltd. won the Pre-A round of financing of 10 million yuan.
It is jointly invested by Weizhi Mathematics Department and Xiaomiao Fund.

• In May, 2022, the company obtained RMB financing of 10 million yuan from Angel Wheel, and the investor was the star of entrepreneurial relay and enlightenment.

Yunshuo IOT Technology (Shanghai) Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Qifu Capital.

• In February, 2021, the company obtained the Pre-A round of 10 million RMB financing, and the investor was Honghu Capital；;
• In May, 2020, the company obtained a strategic investment of RMB 30 million, and the investors were CRB Antriebstechnik GmbH and Huoyan Investment.

Beijing Shudian Technology Co., Ltd. received hundreds of millions of angel round financing.
It is jointly invested by Yaotu Capital and Junlian Capital.

Shenzhen Yunchuang Shu ‘an Technology Co., Ltd. received millions of angel round financing.
Invested by Qifu Capital.

Beijing Yidong Fanxiang Technology Co., Ltd. received 30 million yuan of strategic investment financing.
Invested by Guizhou Innovation Empowerment Big Data Investment Fund.

• In January 2018, the company received a strategic investment of 50 million US dollars, and the investor was Kingdee Strategy;
• In July, 2014, the company obtained a series B financing of RMB 68.405 million. The investors were Northern Lights Venture Capital, IDG Capital, Heguang Capital and Huasoft Investment.
• In October, 2012, the company obtained a series A financing of RMB 13.681 million, and the investor was IDG Capital.

Guangzhou Jiawei Technology Co., Ltd. received 200 million yuan in Series C financing.
Invested by Zhong Ding Capital.

Suzhou Baichuan Data Technology Co., Ltd. was awarded the financing of 10 million yuan angel round.
Invested by Tongchuang Weiye.

Suzhou Washeng Technology Co., Ltd. was awarded a billion-dollar C round of financing.
Invested by Haochen Capital.

• In July, 2022, the company obtained a series B financing of RMB 100 million. The investors were Jinpu Investment, Yuanwang Capital, GGV ggv capital, Haochen Capital and Wanshi Capital (financial advisor);
• In January, 2021, the company obtained a round of financing of RMB 100 million, with GGV ggv capital, Zhong Ding Capital and Yuanwang Capital as investors.

Nanjing Zhongzhiwei Information Technology Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Qi ‘an Investment, Suzhou Xiangcheng Fund and Haibang Investment.

• In September 2022, the company obtained RMB 20 million in Pre-A financing, and the investor was dynamic balance capital;
• In February, 2022, the company obtained the Pre-A round of RMB 20 million financing, and the investors were Rongyi Investment and Chunchuang Investment.

Beijing Rongyi Computing Technology Co., Ltd. received tens of millions of B+ rounds of financing.
Invested by Linzhuo Industrial Fund.

Shanghai Ausuogena Technology Co., Ltd. received several million yuan of Pre-A financing.
It is jointly invested by linear capital, Yunqi capital and Fengwu capital.

Shanghai Lanma Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by IDG Capital, Lianxin Capital and Atom Capital.

Beijing Shuyu Technology Co., Ltd. won the B round of financing
Jointly invested by koala fund and linear capital.

Shanghai Lei Long Information Technology Co., Ltd. received tens of millions of yuan in Series B financing.
Invested by CICC Capital.

Yiqicha Technology Co., Ltd. received 10 million yuan angel round financing.
Invested by the cloud accounting office.

Shenzhen Taiyi Chuanxin Technology Co., Ltd. received several million yuan of Pre-A financing.
It is jointly invested by Zhuode Investment and Tianbo Culture Group.

Hangzhou Ultron Lightyear Internet Technology Co., Ltd. won the Series A financing of 10 million yuan.
It is jointly invested by Caive Fund and Zhenge Fund.

Beijing Xinghan Internet Co., Ltd. received 180 million yuan of undefined financing.
It is jointly invested by Smart Internet Industry Fund, Qianhai Parent Fund and National integration of defense and civilian technologies Industrial Investment Fund.

Hang Seng Baotai (Guangdong) Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Hubei Gaotou Group.

Shenzhen Ant Workshop Technology Co., Ltd. won the C round of financing.
It is jointly invested by Dachen Venture Capital, Shunwei Capital and Longteng Capital.

Beijing Yunjianxin Technology Co., Ltd. received nearly 100 million yuan in Series B financing.
It is jointly invested by North Venture Capital, Sanqi Lexin and Poly Capital.

Netscape Technology Co., Ltd. received tens of millions of A round financing.
It is jointly invested by Guangzhou Investment Group, Guangzhou Tianhe District Guidance Fund and Jianzhi Group.

Arctic Xiongxin Information Technology (Xi ‘an) Co., Ltd. was awarded Series A financing of over 100 million yuan.
Joint investment by Fengnian Capital and Zhengwei Capital.

• In October, 2022, the company obtained financing of+150 million RMB from Angel Wheel, and the investors were Qingdao Runyang, Wei Hao Chuangxin, SMIC Xicheng, iFLYTEK Venture Capital and Cong Weiyi.

Xingyun Zhirong (Shenzhen) Technology Co., Ltd. won a Pre-A round of financing of 10 million yuan.

Guangdong Sanshiyuan Technology Co., Ltd. received tens of millions of B+ rounds of financing.
It is jointly invested by Saitian Capital and Zhongnan Venture Capital.

Granular World (Shanghai) Information Technology Co., Ltd. was awarded RMB 10 million in Series B+ financing.
Invested by BYD.

• In November, 2021, the company obtained the B-round financing of tens of millions of dollars, and the investor was Gaochun Venture Capital;
• In January 2021, the company received a strategic investment of RMB 20 million, and the investor was Hubble Investment.
• In December 2019, the company received A+ round of financing of 20 million US dollars, and the investors were C Capital, Gaochun Capital and Linear Capital;
• In December 2018, the company received a round of financing of RMB 20 million, and the investors were linear capital, door venture capital and linear capital.

Shanghai Fenglei Information Technology Co., Ltd. was awarded Series A financing of over 100 million yuan.
It is jointly invested by Gaoying Venture Capital, CDH Baifu and Tonggao Capital.

Ningxia Yinlang Zhizao Internet Technology Co., Ltd. received tens of millions of angel round financing.

Shenzhen Jianwang Technology Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Zhejiang Energy Fund, CDH Investment, Xiangyue Capital and Small and Medium-sized Venture Capital.

Shenzhen Zhiyuanxin Technology Co., Ltd. received tens of millions of angel round financing.
Invested by Sequoia China.

Beijing Jiuzhang Yunji Technology Co., Ltd. received 80 million yuan of strategic investment financing.
Invested by Huamin.

• In May, 2021, the company obtained a financing of RMB 300 million in Series C, with the investors being Shangyi Capital, SAIF Partners (), Junzi Capital, LinkedIn Capital, Kexi Capital and Zhiyuan Capital (Yitai Chuangfu) (financial consultant);
• In March 2018, the company received RMB 20 million in round B financing, and the investor was Xianghe Capital;
• In October 2014, the company received financing of RMB 4.5 million from Angel Wheel.

Beijing Changyang Software Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Jointly invested by Shenzhen Venture Capital and Xiyu Capital.

Beijing Penghu Wuyu Science and Technology Development Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Zhongwei Yihe and Yuquan Capital.

Beijing Jiliu Technology Co., Ltd. received seed round financing.
It is jointly invested by Qiji Chuangtan, Zhuoyuan Capital, Shuimu Tsinghua Alumni Fund and Enlightenment Star.

Shanghai Zhongdiao Information Technology Co., Ltd. received tens of millions of A++ rounds of financing.
Invested by Oriental Chase.

• In January 2016, the company received RMB 20 million in Pre-A financing, and the investor was Pepsi Group.

Congmai (Shanghai) Information Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Dachen Caizhi.

Beijing Guangtong Youyun Technology Co., Ltd. received 200 million yuan in Series C financing.
It is jointly invested by Songhe Capital, Langmafeng Venture Capital, Qi ‘an Investment, Shunyu Optics and Tianya Capital.

Elephant Huiyun Information Technology Co., Ltd. received 100 million yuan in Series C financing.
It is jointly invested by Guizhou Innovation Empowerment Big Data Investment Fund and Guiyang Guanshanhu Modern Service Industry Development Venture Capital Fund.

Guangyu Mingdao Digital Technology Co., Ltd. received hundreds of millions of angel round financing.
It is jointly invested by Hony Capital, Yuexiu Industrial Fund, Liangjiang Capital, Cangjie Capital and Jinfeng Borun.

Shenzhen Xingwang ICT Technology Co., Ltd. was awarded Series A financing of over 100 million yuan.
It is jointly invested by Guangdong Industrial Development Fund, Shenzhen Investment Control, Haikong Tiancheng Fund and Xiaoxiang Capital.

Hangzhou shuyun Information Technology Co., Ltd. received tens of millions of C+ rounds of financing.
Joint investment by Zhencheng investment and index capital.

• In February 2015, the company obtained financing of RMB 90.91 million in Series C, and the investor was Tongding Internet;
• In May 2014, the company received RMB 20 million in round B financing, and the investor was Sequoia Capital China;
• In September, 2012, the company obtained a series A financing of RMB 13.681 million, and the investor was Sequoia Capital China.

Suzhou Tachibana An Science and Technology Co., Ltd. was awarded the financing of 10 million yuan angel round.
It is jointly invested by Yuanhe Holdings, Suzhou Collaborative Innovation Medical Robot Research Institute and Niu Qunlin.

Shenzhen Xingyi Lianxin Technology Development Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Dongzheng Innovation, Yuan Hang Capital, Aofeilong and Gaomai Capital.

Express logistics

Shenzhen Qianhaida Lu Technology Co., Ltd. received 1 billion yuan in Series C financing.
It is jointly invested by Knowledge City Group, Shanghai Guosheng Investment Group and Shui Mu Chunjin.

• In April 2021, the company received RMB 1 billion in B+ round financing, and the investors were Guosheng Group and Shanghai Chengtou;
• In May 2016, the company received 205 million RMB financing from the seed round, and the investors were SoftBank capital Softbank Overseas, Walden International Investment and Foxconn.

Shenzhen Qianhai Yueshi Information Technology Co., Ltd. received 620 million yuan in Series B financing.
It is jointly invested by COFCO Capital, Shenzhen High-tech Investment, Qifu Capital, Jinzheng Shares, Venture Workshop, Zijin Port Capital and Wanxing Venture Capital.

• In December, 2021, the company received a round of financing of RMB 390 million, with the investors being Venture Workshop, Qifu Capital, Zijin Port Capital, Jinzheng Stock, Tuohua Capital, Wanxing Venture Capital, Changhe Capital, Tang Lei and Extreme Capital (financial consultant).

Hangzhou xiyunda supply chain technology co., ltd. won tens of millions of yuan Pre-A round of financing.
It is jointly invested by Xin Capital, ProLogis and Shenjian Capital.

Shanghai Zhishi Robot Co., Ltd. received tens of millions of angel round financing.
Invested by Lianchuang Yongxuan.

Shenzhen Bangqi Science and Technology Intelligent Development Co., Ltd. was financed by Angel Wheel.
Invested by Zhuoyuan Capital.

Beijing Sinian Zhijia Technology Co., Ltd. was awarded strategic investment financing.
Invested by the newly established group.

• In November, 2022, the company obtained A+ round financing of over RMB 100 million, and the investors were Shui Mu Venture Capital, Rongyi Investment, Chentao Capital, Guangfa Shunde, Hubin Capital and Zhihua Industry.

Anhui Zhichuang Suda Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by the rookie network.

Shenzhen Anyimen Intelligent Supply Chain System Co., Ltd. received tens of millions of angel round financing.

Medical health

Beijing Xiantong International Pharmaceutical Technology Co., Ltd. received over 1.1 billion yuan in Series E financing.
It is jointly invested by SDIC Venture, Jinshi Investment, State Fund, General Venture Capital, CITIC Securities Investment, Tin Venture Capital, SDIC Chuangyi, Yueke Finance, Jimin Credibility, Guangfa Ganhe, Xinshang Investment, Jianggen Capital, Qingshi Zhenhe, Zhizhong Investment, Enran Venture Capital, Lide Measurement and Control, China Life Equity Investment, Hetang Venture Capital, Chengming Capital and Zhongshan Venture Capital.

• In July, 2016, the company obtained a round of financing of RMB 100 million, and the investor was Wuming Investment.

Zhejiang Chongshan Biological Products Co., Ltd. received angel round financing of over 10 million yuan.
Invested by Beijing Meijun.

Suzhou Bingjing Intelligent Medical Technology Co., Ltd. received tens of millions of Pre-A rounds of financing.
It is jointly invested by Daotong Investment, Su Gaoxin Jinkong and Yuanyi Capital.

• In August, 2022, the company obtained the financing of Angel Round in tens of millions RMB, and the investors were Yuanyi Capital and Couplet Health Fund.

Weiyuan Synthetic Biotechnology (Beijing) Co., Ltd. received 100 million yuan of Pre-A financing.
It is jointly invested by Shunxi Fund, Beidaihe New District High-tech Industry Fund and Henan Investment Group.

• In August 2023, the company received RMB 20 million in Pre-A+ financing, and the investor was Jingwei Venture Capital.

Zhichong Pharmaceutical (Beijing) Co., Ltd. received tens of millions of angel round financing.
Joint investment by Lenovo Star and Qiji Chuangtan.

Shanghai Manson Biotechnology Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Hi-Tech Xinjun.

Yafei (Shanghai) Biomedical Technology Co., Ltd. received several hundred million yuan in Series B financing.
It is jointly invested by Hongfu Assets, Xingye Guoxin, Waige Capital and Haiwang Capital.

Taili Biomedical (Hainan) Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Juming Venture Capital, Taikun Fund, Yuanfeng Capital, Sheng Di Investment, Kangxu Investment, Kang Zhe Pharmaceutical and Mint Angel Fund.

Hangzhou Weixin Medical Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Jointly invested by Jinding Capital and Taiyu Investment.

Hangzhou Dishi Medical Biotechnology Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
It is jointly invested by Infineon Capital, Opcom, New Silk Road Capital, Fangfu Venture Capital and Linear Capital.

• In February, 2023, the company obtained the Pre-A round of financing of RMB 20 million, and the investors were linear capital and Gaocheng Venture Capital.

Beijing Yanming Biotechnology Co., Ltd. received 700 million yuan in Series A financing.
It is jointly invested by SDIC Venture Capital, China Venture Capital Fund, Taiping Medical and Health Fund, China Life Science and Technology Innovation Fund, Hetang Venture Capital, Heyu Capital, Lilly Asia Fund, Fengrui Capital, Zhongguancun Development Group, Boyuan Capital, Qinglan Fund, Chang Development, Qisheng Capital and Beijing Life Science Park Venture Capital.

Suzhou Antian Shengshi Pharmaceutical Technology Co., Ltd. won the Pre-A+ round financing of 10 million yuan.
Invested by Herui Venture Capital.

• In December 2022, the company received RMB 20 million in Pre-A financing, and the investor was Herui Venture Capital.

Suzhou Nuojiebei Biotechnology Co., Ltd. received 40 million yuan in Series B financing.
It is jointly invested by Shanghai Biomedical Fund, Detong Capital, Zhongxin Capital, Huitong, Leading Venture Capital, Weidu Capital and Northern Lights Venture Capital.

• In April, 2021, the company received a round of financing of 30 million US dollars, and the investors were Yipu Capital, Weidu Capital, Northern Lights Venture Capital and Yuansheng Venture Capital.

Xinsheng Jiechuang Optoelectronic Technology (Changzhou) Co., Ltd. won tens of millions of yuan in Series B financing.
Invested by Xiyang Capital.

Nanjing Fun Enzyme Biotechnology Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Tongde Capital, Jingyuantong Investment, Thick Investment, Kangju Venture Capital, Nanling Venture Capital and Huaying Equity.

Guangdong Opal Mandy Technology Co., Ltd. received 200 million yuan Pre-IPO financing.
It is jointly invested by Jianxin Equity, Huajin Capital, Guoxin Capital and Binfu Capital.

• In July, 2021, the company received several hundred million RMB financing in D round, and the investors were Chunhua Capital and SDIC.

Nanjing lambotte Animal Pharmaceutical Co., Ltd. received tens of millions of yuan in Series B financing.
It is jointly invested by Zhuopu Investment and Yingmeng Capital.

Qingdao Pangu Robot Co., Ltd. received 10 million yuan angel round financing.
Invested by Dayou Capital.

Qingdao Jianxin Medical Technology Co., Ltd. received tens of millions of A+ rounds of financing.
Jointly invested by Green Venture Capital and Huatong Venture Capital.

Ningbo Huakerun Biotechnology Co., Ltd. received tens of millions of Pre-C+ rounds of financing.
Invested by Shenzhen Hi-tech.

• In July, 2022, the company obtained the financing of RMB 100 million in Series C, and the investors were Hangzhou Bay Investment and Ningbo Jierui.

Shenzhen Fuwo Pharmaceutical Co., Ltd. won the B+ round of financing.
Invested by Zhongguancun Development Sailing Industry Investment Fund.

• In July, 2023, the company received A+ round financing of RMB 20 million, and the investors were Nanshan Zhanxintou, Zhongguancun Development Qihang Industrial Investment Fund, Lihe Kechuang and Gongqingcheng Yunkun Fund;
• In September, 2021, the company received a round of financing of RMB 20 million, and the investors were Lihe Kechuang and Yaoxiantong New Drug Base.

Suzhou Biyang Pharmaceutical Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Shengsu New Medicine, Tianxiang Industry and Juming Venture Capital.

Shanghai Xinhengrui Medical Technology Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by IDG Capital, Waig Capital and Langmafeng Capital.

Xiande Medical Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Qingchi Capital and Hong Kong Asia Medical Group.

Hangzhou Deruizhi Pharmaceutical Technology Co., Ltd. was awarded the A+ round of financing of over 20 million yuan.
Invested by Shenuo.

• In December, 2021, the company received a round of financing of 20 million US dollars, and the investors were Huagai Capital, Songhe Capital and Sherpa Investment.

Tianjin Hengyu Medical Technology Co., Ltd. won the D round of financing.
Invested by Jin Huitong.

Haimai Medical Technology (Suzhou) Co., Ltd. was awarded Series A financing.
Invested by Shanghai Biomedical Fund.

• In March, 2023, the company received RMB 20 million in Pre-A financing, and the investors were tahoe Venture Capital and Leading Venture Capital.
• In June, 2022, the company received financing of RMB 20 million from Angel Wheel, and the investor was Huafang Capital.

Qiuhang (Zhejiang) Health Management Co., Ltd. won the Pre-A round of financing.
It is jointly invested by Fanzhi Medicine and Fanzhi Cloud Chain Ecological Chain Enterprise Platform.

Jiangsu Jiyuan Medical Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Shanlan Capital and Qingzheng Capital.

Bangkece (Shanghai) Intelligent Medical Technology Co., Ltd. received nearly 100 million A+ rounds of financing.
Jointly invested by Shenzhen Venture Capital and Chinese Medical Capital.

Jingzhi Future (Guangzhou) Intelligent Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Fosun Chuangfu, Science City Venture, Guangdong-Hong Kong-Macao Greater Bay Area Collaborative Innovation Research Institute and Shanghai Jun Tiancheng.

• In June, 2021, the company received financing of RMB 20 million from Angel Wheel, and the investor was Zhenge Fund.

Sichuan Xieguang Biotechnology Co., Ltd. received nearly 100 million yuan in Series B financing.
Jointly invested by Herbal Capital and Yuansheng Venture Capital.

Gaowei Medicine (Hangzhou) Co., Ltd. received tens of millions of angel round financing.
It is jointly invested by Beida Pharmaceutical and Industrial Investment Fund of West Lake University.

Harbin Shengnuo Medical Technology Co., Ltd. received 18 million yuan Pre-A round of financing.
Joint investment by Shenzhen Venture Capital and Suiyong Chenneng.

Zhejiang Haizheng Sulikang Biotechnology Co., Ltd. won the B round of financing.
It is jointly invested by Zhong Ding Capital, Yuanquan Industry and Yang Jiyong.

Hefei Aiqutuoou Technology Co., Ltd. received millions of seed rounds of financing.
Invested by Starway Health.

Nuofeng Pharmaceutical (Chengdu) Co., Ltd. received tens of millions of yuan in Series B financing.
Invested by Hengbao Protection.

• In August, 2021, the company received a round of financing of RMB 20 million, and the investors were Deyi Capital and Saiying Capital.

Kaben (Shenzhen) Medical Technology Co., Ltd. was awarded Series A financing of over 100 million yuan.
Jointly invested by Tongchuang Weiye and Jinding Capital.

• In August, 2022, the company obtained the Pre-A round of RMB 20 million financing, and the investors were Jinding Capital and Small and Medium-sized Venture Capital.

Shenzhen Zhichu Computer System Co., Ltd. won Pre-A round of financing.
Invested by Hainan gaojie.

• In March, 2023, the company obtained a strategic investment of RMB 10 million, and the investors were Lamu, Luyou Venture Capital, Yuanzhen Venture Capital, Hongxiu Capital and Fei Gesheng.
• In July, 2020, the company obtained financing of RMB 2 million from Angel Wheel, and the investors were Hongtaizhi Workshop and Yuanzhen Value Investment.

Shanghai Jiamuyao Medical Technology Co., Ltd. received tens of millions of yuan in Pre-A financing.
It is jointly invested by Hongsheng Capital, Yuansheng Venture Capital and Haimeide Venture Capital.

Ming Lan Shijia (Beijing) Medical Technology Co., Ltd. received seed round financing.
Invested by Yuanyi Capital.

Shenzhen Fuwo Pharmaceutical Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Nanshan Zhanxintou, Zhongguancun Development Qihang Industrial Investment Fund, Lihe Kechuang and Gongqingcheng Yunkun Fund.

• In September, 2021, the company received a round of financing of RMB 20 million, and the investors were Lihe Kechuang and Yaoxiantong New Drug Base.

Suzhou Zhuzheng Robot Co., Ltd. received nearly 100 million yuan in Series B financing.
It is jointly invested by Puhua Capital and Su Gaoxin Financial Holdings.

Mirui (Hangzhou) Biotechnology Co., Ltd. received 50 million yuan in Series D financing.
It is jointly invested by Fupu Investment, EDB Investments, Mitsui, Novell Venture Capital and Singapore Science and Technology Research Council.

• In October, 2021, the company obtained a series C financing of RMB 87 million. The investors were China Resources Zhengda Life Science Fund, Rock Springs Capital, EDBI, CCB International, Triumph Venture Capital, Nuohui Investment and Chenling Capital.

Hangzhou Dilan Biotechnology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Zhejiang Collaborative Innovation and Hangzhou Jinsheng.

• In August, 2022, the company received a round of financing of RMB 20 million, and the investors were Zhongying Investment, Saizhi Bole and Zhejiang Laiyi.

Luken (Shanghai) Medical Technology Co., Ltd. received 35 million yuan in Series A financing.
Jointly invested by Tongde Capital and Shanghai Xinyoutuo.

Shenzhen Yurucheng Dental Materials Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Pickup Capital and Zijin Port Capital.

Shanghai Xinsu Medical Technology Co., Ltd. won the Pre-A+ round of financing of billion yuan.
It is jointly invested by Lvdong Capital, Rehabilitation Capital, Ali Health, Fengrui Capital, Qiming Venture Capital, Xinhang Capital and Huatai Zijin.

Zhejiang Haisi Biomedical Technology Co., Ltd. received angel round financing of over 10 million yuan.
Invested by Zijin Port Capital.

Huake Precision (Beijing) Medical Technology Co., Ltd. won over 100 million yuan in D+ round financing.
It is jointly invested by Deno Capital, Cinda Kunpeng, Shui Mu Investment, Junshan Capital and Huiyu Investment.

• In December, 2022, the company received nearly RMB 300 million in D round of financing, and the investors were China-US Green Yangtze River Delta, Deno Capital, Rongquan Capital and Kaifeng Venture Capital.

Xinhanglu Medical Technology (Guangzhou) Co., Ltd. received 200 million yuan in Series A financing.
Longpan Investment and Lilly Asia Fund jointly invested.

Hainan Leyun Biotechnology Co., Ltd. received tens of millions of yuan in Series B financing.
Invested by Seders Group.

China Boron Neutron Technology (Hangzhou) Co., Ltd. was granted angel round financing of over 100 million yuan.
It is jointly invested by Cailletet Capital, Nuoyu Capital, Zhongke Chuangxing and Kunlun Capital.

Shenzhen Zhenmai Biotechnology Co., Ltd. received nearly 400 million yuan in Series C financing.
It is jointly invested by Jinyu Medicine, Guo Xin Investment, Shenzhen Hi-tech Investment, Guochuang Zhiyuan, Shuangye Venture Capital and Caixin Capital.

• In September, 2021, the company received RMB 410 million in B+ financing, and the investors were Shengxiang Bio, Tongchuang Weiye, Kexi Capital, China-Europe United Capital and Chishi Capital.

Xinshiyan Medical Technology (Hangzhou) Co., Ltd. was awarded Series A financing of over 100 million yuan.
It is jointly invested by Stor Capital, Sherpa Investment and Airui Investment.

• In September, 2022, the company received A+ round of financing of RMB 20 million, and the investors were Sequoia China Seed Fund and Hangzhou Heda Biomedical Industry Fund.

Hangzhou Kechang Technology Consulting Co., Ltd. was awarded strategic investment financing.
Invested by Tiger Medicine.

• In April 2016, the company received a round of financing of RMB 20 million, and the investor shared the investment;
• In October 2015, the company received RMB 20 million in Pre-A financing, and the investor was Shanghai Dezhihe Investment.

Kunshan Yiyuan Medical Technology Co., Ltd. won the B round of financing.
It is jointly invested by Langmafeng Venture Capital, Jiangsu Hi-Tech Industrial Investment and Ronghui Capital.

Shanghai Lidao Pharmaceutical Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Shanghai Biomedical Fund, Ke Zhang Lingyi, Hongfeng Investment and Hongke Baishi.

Beijing Jinlan Gene Technology Co., Ltd. received tens of millions of yuan in Pre-B round financing.
Invested by Guoke Jiahe.

• In February, 2022, the company received a round of financing of RMB 200 million, with Huajin Investment, Yizhuang Guotou, Oriental Fuhai, Shenzhen Venture Capital, Saiying Capital, Kangju Venture Capital and Kaicheng Capital (financial consultant) as investors;
• In February, 2021, the company obtained financing of RMB 200 million from Angel Wheel, and the investors were Oriental Fuhai, Yuansheng Venture Capital, Shennuo Chentu and Saiying Capital.

Xiushi Biomedical (Nantong) Co., Ltd. received tens of millions of angel round financing.
Invested by Pickup Capital.

Suzhou Bangqi Biotechnology Co., Ltd. received tens of millions of A+ rounds of financing.
Jointly invested by Qifu Capital and Relay Fund.

Shiwei Image (Henan) Technology Co., Ltd. received tens of millions of strategic investment financing.
Invested by Huaxia ophthalmology.

• In March, 2023, the company obtained a financing of RMB 300 million in the C round, and the investors were China Life Equity Investment, Qianhai Ark, Chende Capital, Shenzhen Venture Capital, Zhongjin Huirong, Yida Capital, Lingang Lanwan Capital, Xiaoming Investment, Yuhua Fund and Feitu Venture Capital;
• In January, 2021, the company received a series B financing of RMB 100 million. The investors were Feitu Venture Capital, Langsheng Investment and Shaanxi Investment Yuhua.

Chongqing Zhijian Life Science and Technology Co., Ltd. won the Pre-A round of financing of 10 million yuan.
Invested by Yangming Capital.

Biomedical Technology Holding Co., Ltd. was granted strategic investment financing.
Invested by Yingjian Medical.

Suzhou Yuanxing Zhizao Technology Co., Ltd. received tens of millions of angel round financing.
It is jointly invested by Xianfeng Qiyun, Shangshi Capital and Changan Private Capital.

Wuhan Newforth Biotechnology Co., Ltd. received 700 million yuan of C+ round financing.
It is jointly invested by CMB International Capital, Optics Valley Financial Control, Wuhan Hi-Tech, Optics Valley Health, Guangzhou Financial Control, SDIC Investment Promotion, Paradise Silicon Valley and Yangtze River Investment.

• In November, 2021, the company obtained the financing of RMB 400 million in Series C, and the investors were China Investment, Sequoia Capital China, Sunshine Insurance and CMB International.
• In February, 2021, the company received a series B financing of RMB 400 million, with the investors being Huaxin Investment, Yuanfang Capital, Yuanhe Holdings, Sequoia Capital China, Northern Lights Venture Capital, Guofeng Capital and Huiyuan Capital;
• In April, 2020, the company obtained a series A financing of RMB 130 million, and the investors were sequoia capital china, Fuxing Future Capital and Northern Lights Venture Capital.

Hebei Nake Biotechnology Co., Ltd. received tens of millions of strategic investment and financing.
It is jointly invested by Longmen Capital, Shijiazhuang Ketou and Shuiyang.

Jiangsu Bochuang Biotechnology Co., Ltd. was financed by Angel Wheel+.
It is jointly invested by Jiasheng Venture Capital and Christine.

Kaisi Kaidi (Shanghai) Pharmaceutical Technology Co., Ltd. received 140 million yuan in Series A financing.
It is jointly invested by Puhua Capital, Guoke Investment, Huiding Investment, Longpan Investment and Xinyi Holdings.

Suzhou Pilotage Biotechnology Co., Ltd. received hundreds of millions of D rounds of financing.
It is jointly invested by Lilly Asia Fund and Sherpa Investment.

• In December, 2021, the company obtained the financing of several hundred million yuan in Series C, and the investors were Guangfa Ganhe, Gaoying Investment, Sherpa Investment, New Hope Group and Hunan Caixin.

Shaoxing Mayo Magnetic Medical Technology Co., Ltd. was awarded the A+ round of financing.
Invested by Chuangrui.

• In December 2019, the company received financing of RMB 10 million from Angel Wheel, and the investors were Shun ‘an Investment, Ruijia Medical Association and individual investors.

Zuodian Health Industry (Shenzhen) Co., Ltd. received over 100 million yuan in Series B financing.
Invested by Zhongjin Huirong.

• In December, 2020, the company obtained the A+ round financing of RMB 100 million, and the investors were Gaocheng Venture Capital, Qingliu Capital, Tiantu Investment, Tongchuang Weiye and Country Garden Venture Capital.

Shanghai Huanma Biomedical Co., Ltd. received tens of millions of yuan in Series A financing.
Jointly invested by JJDC and Superstring Fund.

• In December, 2021, the company obtained the Pre-A round of financing of RMB 20 million, and the investors were Xianfeng Qiyun, Kunlun Capital, Yifeng Capital and Cailletet Capital.

Beijing Yuanyu Biotechnology Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Hengxu Capital, Thick Investment and Yazhouwan Venture Capital.

Weiyuan Synthetic Biotechnology (Beijing) Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
Invested by Jingwei Venture Capital.

• In July, 2023, the company obtained the Pre-A financing of RMB 100 million, and the investors were Shunxi Fund, Beidaihe New District High-tech Industry Fund and Henan Investment Group.

Boyin Listening Technology (Shanghai) Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Junlian Capital and Mingxi Capital.

Guangzhou Bositao Controlled Release Pharmaceutical Co., Ltd. received several hundred million B+ rounds of financing.
It is jointly invested by Yueke Finance, Chuangyu Investment, BOC Yuecai, Ant Rice Fund, Wanlian Guangsheng, Wanlian Tianze, October Capital, Causal Investment, Knowledge City Group and Guangzhou Panyu Fund.

Juxin Medical Technology (Shenzhen) Co., Ltd. received nearly 100 million yuan in Series B financing.
It is jointly invested by Turing Asset Management, Zhuhai High-tech Investment, Qinzhi Capital and Chengdu Chuanghe Ruixin.

Dianjing Biomedical Technology (Suzhou) Co., Ltd. won the B+ round of financing.
Jointly invested by Yuanhe Chenkun and Suzhou Yihe.

• In February, 2023, the company obtained the second round of financing of over USD 40 million, and the investors were Qianji Capital, Yuexiu Industrial Fund, Herbal Capital, Yuanhe Holdings, Lilly Asia Fund, Gaoying Venture Capital and Quanchuang Capital.

Jiangsu Puxin Biomedical Co., Ltd. received tens of millions of A+ rounds of financing.
Invested by the Sage Foundation.

• In April, 2023, the company received a round of financing of RMB 20 million, and the investors were Jiarui Investment and Hesheng Capital.

Hefei Hanke Maibo Biotechnology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Guoyuan Equity Investment, Guoyuan Innovation Investment, iFLYTEK Venture Capital and Shengzhong Investment.

Shanghai Shengzhe Medical Technology Co., Ltd. won the B round of financing.
Invested by Qiming Venture Capital.

• In March, 2021, the company received a round of financing of RMB 100 million, and the investors were Qiming Venture Capital and Taifu Capital.
• In December 2019, the company received RMB 20 million in Pre-A financing, and the investors were Northern Lights Venture Capital and Longpan Investment.

Miaoshun (Shanghai) Biotechnology Co., Ltd. was awarded Series A financing of over 100 million yuan.
It is jointly invested by Zhongke Haichuang, Yida Capital, Gaoyao Venture Capital, Titan Technology and Tongyu Fund.

Nanjing Yixi Biotechnology Co., Ltd. received nearly 100 million yuan in Pre-A+ financing.
It is jointly invested by Huangpu Pharmaceutical Fund, Yuanhe Holdings, Clivia, Yizhan Capital, Nanwan Baiao Fund, Oasis Capital and Shenzhen High-tech Investment.

• In October 2019, the company received RMB 10 million in financing from Angel Wheel.

Shenzhen Jingtuo Biotechnology Co., Ltd. won the Pre-A round of financing of 10 million yuan
Newly invested by Nanshan War.

Shenzhen Yangqi Yixin Intelligent Technology Co., Ltd. received tens of millions of angel round+financing.
It is jointly invested by Hong Kong X Science and Technology Fund, Trunk Road Fund and Sequoia China Seed Fund.

• In November, 2022, the company obtained financing of RMB 20 million from Angel Wheel, and the investors were Yuansheng Venture Capital and Sequoia China Seed Fund.

Shenzhen Alpha Molecular Technology Co., Ltd. was awarded Series A financing.
It is jointly invested by Shanghai Biomedical Fund, Huaqian Capital and Xinhenglida.

Weihai Weigaojie Likang Biomaterials Co., Ltd. received several hundred million yuan in Series A financing.
It is jointly invested by Zhouji Tongli Assets, Qingdao Chuangjing Fund, China Merchants Securities and Weihai Investment Group.

Shanghai Fuyi Medical Technology Co., Ltd. was awarded Series A financing.
Jointly invested by Sequoia China and Daotong.

Beijing Ansong Technology Co., Ltd. received 100 million yuan in Series C financing.
It is jointly invested by Safran Investment and China Development Capital.

Yipin (Guiyang) Quality Technology Co., Ltd. received tens of millions of C+ rounds of financing.
Invested by October Capital.

• In October, 2021, the company obtained the financing of RMB 20 million in Series C, and the investors were Power Capital, Oriental Fuhai and Guiyang Venture Capital.
• In March, 2021, the company received RMB 10 million in B+ financing, and the investors were Zhonghe Ruimin, Baten Capital and Guiyang Venture Capital.

Suzhou Aikailiyuan Biotechnology Co., Ltd. won the A++ round of financing of billion yuan.
It is jointly invested by Zhiyi Investment and Xihu Branch Venture Capital.

Shenzhen Xinhuan Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Invested by Luxin Venture Capital.

Mandi Medical Instrument (Shanghai) Co., Ltd. received nearly 100 million yuan in A+ round financing.
Invested by Xinding Capital.

• In September, 2021, the company obtained a series A financing of RMB 100 million, and the investors were Guoke Holdings, Guo Xin Capital, Shanghai Institute of Microsystems, Chinese Academy of Sciences, Shanghai Xinwei Group and Chinese Academy of Sciences Capital.

Chengdu Han Guang Chen Wing Technology Co., Ltd. won over 300 million yuan in B+ round financing.
It is jointly invested by Qingchi Capital, Guotai Junan Venture Capital, Daotong Investment, Junlian Capital, Zhouling Capital, Xunzheng Venture Capital and Guosheng Capital.

• In September, 2021, the company received a round B financing of RMB 200 million. The investors were Junlian Capital, Boyuan Capital, Yunzhi Capital, Northern Lights Venture Capital, innovation works and LYFE Capital Zhouling Capital.
• In July 2018, the company received a round of financing of RMB 20 million, and the investors were Fosun Group and Boyuan Capital.

Zhejiang Maidesite Medical Device Technology Co., Ltd. received nearly 100 million yuan in angel round financing.
It is jointly invested by Yuanning Investment, Hengxu Capital and Yu Xiang Medical.

Chengdu Taihe Weiye Biotechnology Co., Ltd. won the A+ round of financing.
It is jointly invested by Shengde Yuekai, Zhongjin Capital and Gaoyao Venture Capital.

• In September, 2023, the company received a round of financing of RMB 200 million, and the investors were Shengde Yuekai, Zhongjin Capital and Gaoyao Venture Capital.

Jinfan Biomedical Technology (Wuhan) Co., Ltd. was awarded Series A financing.
It is jointly invested by SDIC and Hongxin Capital.

Shenzhen Wellvision Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Invested by Blue Bay Venture Capital.

Yijieli Branch (Shanghai) Biotechnology Co., Ltd. received 32 million yuan in Series A financing.
It is jointly invested by Qiming Venture Capital, Aobo Capital and Morningstar Venture Capital.

Guangzhou Huateng Biomedical Technology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Yanghe Investment and Wanlian Tianze.

• In September, 2022, the company received a round of financing of RMB 20 million, and the investor was Zhongke Yuechuang.

Ruilong Nuofu (Shanghai) Medical Technology Co., Ltd. received nearly 200 million yuan in Pre-B financing.
It is jointly invested by Nuelle Capital, Yipu Capital, Lilly Asia Fund, Weiwu Capital, Jingwei Venture Capital, GGV ggv capital and LRI Jiangyuan Investment.

• In December, 2022, the company obtained the Pre-B round of financing of 20 million US dollars, and the investors were LRI Jiangyuan Investment, Lilly Asia Fund, Weiwu Capital, Jingwei Venture Capital and GGV ggv capital;
• In April, 2021, the company obtained Series A financing of several hundred million RMB, and the investors were Jingwei China, Weiwu Capital, GGV ggv capital and Lilly Asia Fund.

Kangpu Biomedical Technology (Hefei) Co., Ltd. received nearly 100 million yuan in B+ round financing.
It is jointly invested by Yicun Capital, Northern Lights Venture Capital, Longpan Investment, Yijing Capital, Swiss Joint Venture Capital and Ginkgo Valley Capital.

Suzhou fumailei medical technology co., ltd won the Pre-A+ round of financing.
It is jointly invested by unlimited fund SEE Fund and Woyong Fund.

Shanghai Zhaoguan Electronic Technology Co., Ltd. received tens of millions of D round financing.
It is jointly invested by Huashan Capital and Changzhou Government Investment Fund.

• In July 2018, the company received RMB 8 million in Series B financing, and the investors were Star VC and Qianhai Parent Fund.

Suzhou three cobblers biotechnology co., ltd. received tens of millions of yuan Pre-B round of financing.
Joint investment by Shenzhen Venture Capital and Kaicheng Capital.

Hefei Harbin Institute of Intelligent Technology Co., Ltd. received tens of millions of angel round financing.
Invested by Hefei Ai Orchard.

Pengtuo Biotechnology (Hangzhou) Co., Ltd. received tens of millions of yuan in Pre-A financing.
It is jointly invested by Tongfang Investment, Zheshang Jiantou and Zijin Port Capital.

Van Enkel Biotechnology (Zhongshan) Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Zhuhai Hecheng Zhiyi, Huaying Health, Renxi Fund, Beijing Yishang Huicheng and Dilianxing.

Shandong Aikeda Biotechnology Co., Ltd. received tens of millions of A+ rounds of financing.
Invested by Shandong New Kinetic Energy Fund.

• In September, 2022, the company obtained a round of financing of over RMB 100 million, and the investors were Yida Capital and CITIC Medical Fund.

Chengdu Taihe Weiye Biotechnology Co., Ltd. received 200 million yuan in Series A financing.
It is jointly invested by Shengde Yuekai, Zhongjin Capital and Gaoyao Venture Capital.

Ketaiya Biotechnology (Shanghai) Co., Ltd. received 250 million yuan in Series B financing.
It is jointly invested by Hengxu Capital, Stowe Capital, Henan Huirong and Food Core Capital.

• In November, 2022, the company obtained A+ round financing of over 100 million RMB, and the investors were Sequoia China, Stowe Capital, Source Capital and Food Core Capital;
• In May, 2022, the company obtained a series of financing of several hundred million RMB, with the investors being source capital, food core capital, Sherpa investment and Yuanqi capital (financial consultant).

Zhuhai Shutong Medical Technology Co., Ltd. was awarded Series A financing.
It is jointly invested by Shaanxi Investment Growth Fund, Guangdong Finance, Kaide Fund and Hua Nuo Medical Fund.

• In July, 2022, the company obtained financing of RMB 20 million from Angel Wheel, and the investors were Yunfeng Fund, Gree Electric, Zhonghui Investment and Good Governance Investment.

Guangzhou Meiyang Innovation Technology Co., Ltd. received nearly 100 million yuan in Pre-A round of financing.
It is jointly invested by Boyuan Capital, Jinding Capital, Rehabilitation Capital and Chuangdong Investment.

Jiangsu Sanshu Biotechnology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Jointly invested by Nantong Investment Management and Zhigeng Fund.

Innovac Therapeutics received 18 million yuan of Pre-A financing.
It is jointly invested by Elikon Venture, Vision Plus Capital, Yunion Healthcare Ventures and TG Sino-Dragon Fund.

Hangzhou Leyi Biotechnology Co., Ltd. was financed by Angel Wheel+.
It is jointly invested by Thunderstorm Capital and Yuhang Financial Holdings.

Jiangsu Guan Ai Medical Technology Co., Ltd. received 100 million yuan of C+ round financing.
It is jointly invested by Hi-Tech Xinjun, Jianxin Equity and Shunbai Capital.

• In June, 2023, the company obtained C round of financing of several hundred million RMB, and the investors were China Life Equity Investment and Zhongjin Qide Fund;
• In January, 2022, the company obtained a series B financing of several hundred million RMB. The investors were Boyuan Capital, Sherpa Investment, Cornerstone Capital and Wuzhong Biomedical Industry Fund.

Beijing Leiao Dingfeng Biotechnology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Jianyi Capital and Huagai Capital.

Zhuhai Shali Biotechnology Co., Ltd. received 400 million yuan in Series B financing.
It is jointly invested by CICC Capital, Qianhai Parent Fund, Liandong Group, Yuanhe Capital, Sherpa Investment, Decheng Capital, Jingwei Venture Capital and Hefangtian.

• In December, 2020, the company obtained a series A financing of RMB 100 million, and the investors were Decheng Capital, Jingwei China and Sherpa.

Shanghai Lanjia Medical Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Jointly invested by Zhangjiagang Industrial Capital Center and Zhangjiagang Phoenix Technology.

Guangdong Bogong Medical Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Invested by Green Orange Capital.

Shenzhen Shengqiang Technology Co., Ltd. received over 100 million yuan in Series B financing.
Investment is invited by SDIC.

Hangzhou Aorui Biotechnology Co., Ltd. received nearly 100 million yuan of B+ round financing.
It is jointly invested by Dachen Caizhi, Daoyuan Capital and Hot View Bio.

• In January, 2022, the company received a series B financing of RMB 100 million, and the investor was Hot View Bio.

Hangzhou Ruier Weikang Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Nuoyu Capital and Ye Huahua.

Shenzhen Taisheng Biotechnology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
Invested by Fuzeng Fund.

Sichuan Chaoying Pharmaceutical Co., Ltd. received tens of millions of angel round financing.
It is jointly invested by Northern Lights Venture Capital and Haining Hanchi.

Jiangxi Lizhi Youfang Management Consulting Co., Ltd. received millions of angel round financing.
Invested by the Huang Xiaolang family office.

Guangzhou Hanteng Biotechnology Co., Ltd. received over 300 million yuan in Series C financing.
It is jointly invested by SDIC Venture, Guangdong Finance, Taipu Life Science Investment and Ganyin Investment.

Beijing Meibai Pharmaceutical Biotechnology Development Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Sanze Venture Capital, Caixin Industry Fund and Beijing Xinhangcheng.

• In August, 2021, the company received a round of financing of RMB 20 million, and the investors were Yahui Precision Medical Fund, Century Jinyuan, Danlu Capital and Xinghan Capital (financial advisor);
• In February, 2021, the company obtained financing of RMB 20 million from Angel Wheel, and the investor was Danlu Capital.

Whale Hunters (Beijing) Intelligent Technology Co., Ltd. has received tens of millions of angel round financing.
It is jointly invested by Tongchuang Weiye, Capital Science and Technology Development Group, Yingnuo Capital and Shuimu Tsinghua Alumni Fund.

Mengmou (Chengdu) Biotechnology Co., Ltd. received tens of millions of angel round financing.
Invested by Beijing Life Science Park Venture Capital.

Henan Kaipurui Biotechnology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.
It is jointly invested by Huangpu Pharmaceutical Fund and Yabao Pharmaceutical.

Sain Medical Technology (Lianyungang) Co., Ltd. received tens of millions of yuan in Pre-A financing.
Invested by Tianhui Capital.

Kuanteng (Beijing) Medical Equipment Co., Ltd. was awarded RMB 100 million in Series C financing.
It is jointly invested by CICC Capital, Strait Equity Fund and Zhongchen Guochi.

Suzhou Yatong Biomedical Technology Co., Ltd. received nearly 100 million A+ rounds of financing.
Jointly invested by Trunk Road Fund and Borun Capital.

• In August, 2022, the company obtained a round of financing of nearly RMB 100 million, and the investors were Xingze Capital, Wuxi Guolian Xinchuang, Borun Capital, Zhejiang Hongshi and Kaicheng Capital (financial consultants).

Tianjin Century Kangtai Biomedical Engineering Co., Ltd. won the B round of financing.
It is jointly invested by SDIC Chuanghe, Yifeng Capital, Songshan Lake Science City Group, Xiaochi Capital and Jinju Investment.

Saiyuan Biotechnology (Hangzhou) Co., Ltd. received tens of millions of yuan in Series C financing.
It is jointly invested by Zijin Port Capital and Yuhang Guotou Group.

• In February, 2022, the company obtained nearly RMB 100 million in round B financing, and the investors were Jifeng Capital and Kunlun Capital.
• In July 2021, the company received a strategic investment of RMB 20 million, and the investor was Kunlun Capital.

Shanghai Ligetai Biotechnology Co., Ltd. received hundreds of millions of D rounds of financing.
It is jointly invested by Xinda Kunpeng, Hanshi Investment, Jianxin International Trade and Junlian Capital.

Beijing Fanzhi Medical Technology Co., Ltd. received 100 million yuan in Series D financing.
Jointly invested by Jianchuang Medical Growth Fund, Jinshajiang Capital and Zhilai Investment.

• In December, 2020, the company received a round B financing of RMB 20 million, and the investors were Qingfeng Zichuang and Tianjin Kechuang.

Lingke Pharmaceutical (Hangzhou) Co., Ltd. was awarded Series C financing.
It is jointly invested by Binhai New Area Biomedical Industry Equity Investment Fund, Haibang Investment, Good Buy Fund, New Alliance Capital and Lilly Asia Venture Capital Company.

• In May, 2023, the company received a C+ round of financing of RMB 200 million, and the investors were Shengshi Investment, Tailong Investment and Liandong Investment.
• In April, 2020, the company received a round of financing of 20 million US dollars, and the investors were Decheng Capital, Zheshang Venture Capital, Cailletet Capital and Power Capital;
• In April 2018, the company received $20 million in financing from Angel Wheel, and the investors were Kaitai Capital, Sinopharm Capital and Power Capital.

Hangzhou Qihan Biotechnology Co., Ltd. received 100 million yuan of Pre-B round financing.
Invested by Zhejiang Jinkong.

Beijing Xinyun Medical Technology Co., Ltd. received tens of millions of yuan in Series B financing.
Jointly invested by Zhangjiagang Industrial Capital Center and Yangzijiang Metallurgical Industrial Park.

• In April 2019, the company received a round of financing of RMB 20 million, and the investors were Jinke Junchuang, Zhonglu Capital, Lenovo Star and Lao Bacon Fund;
• In January 2018, the company received RMB 20 million in Pre-A financing, and the investor was Lenovo Star.

Hangzhou Ruiao Biomedical Co., Ltd. received tens of millions of Pre-A+ rounds of financing.
It is jointly invested by Oriental Jiafu, West Lake Education Foundation, Time Capital and West Lake Venture Capital.

Shanghai Yixin Medical Equipment Co., Ltd. received nearly 100 million yuan in Series C financing.
It is jointly invested by Datong Capital, Tonghe Yucheng, Jiading Venture Capital, Haiheng Capital, Hefei Investment Capital, Anyuan Fund and Binhu Science City.

Beijing Huimei Technology Co., Ltd. received more than 300 million yuan in Series D financing.
It is jointly invested by Zhong Ding Capital, Runzhang Venture Capital, Suzhou Yihe and Qiming Venture Capital.

• In August 2019, the company received a $30 million financing in Series C, and the investors were Qiming Venture Capital, Wuxi PharmaTech and Huimei Capital.

Sichuan Anaerobic Biotechnology Co., Ltd. was awarded strategic investment financing.
Invested by Wan Ze.

• In August, 2022, the company received a round of financing of RMB 100 million, and the investors were Daotong Investment, Chengdu Science and Technology Venture Capital, Chuangdong Investment and Zhongxi Fund.
• In July 2021, the company obtained tens of millions of RMB financing in Pre-A round, and the investor was Daoyuan Capital.

Nafei (Shenzhen) Pharmaceutical Technology Co., Ltd. received tens of millions of yuan in Series A financing.
Jointly invested by Cailletet Capital and Yayi Capital.

• In October 2021, the company obtained RMB 20 million in Pre-A financing, and the investor was Kaitai Capital.

Guangzhou Maijinjia Biotechnology Co., Ltd. received tens of millions of A+ rounds of financing.
It is jointly invested by Science City Venture and Knowledge City Group.

Shanghai Zhiyu Software Information Co., Ltd. received several million yuan of Pre-A financing.
You yongli financial investment.

Beijing Zhongyin Technology Co., Ltd. won the B round of financing.
It is jointly invested by Kunlun Capital and Jinpu Investment.

• In March, 2021, the company obtained the Pre-A round of financing of 70 million RMB, and the investors were Hetang Venture Capital (Qidi Venture Capital) () and Longmen Capital.

Internet applications and services

Heduo Technology (Beijing) Co., Ltd. received 300 million yuan of C+ round financing.
It is jointly invested by Yueke Finance and Guangzhou Automobile Capital.

• In October 2017, the company received $10 million in financing from Angel Wheel. The investors were IDG Capital, NavInfo, Zhixing Technology and Bertelsmann Asia Investment Fund.

The strategic investment financing of Changchun Yihang Intelligent Technology Co., Ltd.
It is invested by BAIC.

• In March 2019, the company received RMB 100 million in B+ round financing, and the investor was Guangzhou Automobile Group;
• In August, 2018, the company received a series B financing of RMB 220 million. The investors were Jingwei Venture Capital, CICC, Source Capital, Zhongjin Jiazi, Jingwei China and Zhongjin Jiacheng;
• In August 2016, the company obtained financing from Angel Wheel in undisclosed US dollars, and the investor was Mingshi Capital.

Hangzhou Huaxiangyun Technology Co., Ltd. received 1 million yuan angel round financing.
Invested by Taihe Zhigu.

Shanghai Jianyi Technology Co., Ltd. was awarded Series A financing.
Invested by IDG Capital.

Nanjing Zhongzhiwei Information Technology Co., Ltd. received nearly 100 million yuan in Series A financing.
It is jointly invested by Qi ‘an Investment, Suzhou Xiangcheng Fund and Haibang Investment.

• In September 2022, the company obtained RMB 20 million in Pre-A financing, and the investor was dynamic balance capital;
• In February, 2022, the company obtained the Pre-A round of RMB 20 million financing, and the investors were Rongyi Investment and Chunchuang Investment.

Shanghai Elabi Intelligent Technology Co., Ltd. won the B+ round of financing of over 100 million yuan.
Jointly invested by Juzhuo Capital and Guoke Xinneng.

• In September 2018, the company received RMB 10 million in Pre-A financing.

Zhejiang Xinhua Mobile Media Co., Ltd. received tens of millions of yuan in Series A financing.
Invested by Cape Cloud.

Shenzhen Dalezhuang Construction Technology Co., Ltd. was awarded the B+ round of financing.
Invested by China Merchants Shekou.

education

A little knowledge (Beijing) Technology Co., Ltd. won tens of millions of yuan in Pre-A round of financing.
Joint investment by Zhencheng Investment and Xu Zhoujin.

Beijing Heqi Juli Education Technology Co., Ltd. received tens of millions of yuan in Series C financing.
It is jointly invested by Dening Capital and Koala Fund.

Cultural entertainment

Hainan Shuhe Technology Co., Ltd. received tens of millions of yuan in Pre-A round of financing.

Hangzhou Knowledge Matrix Information Technology Co., Ltd. received tens of millions of yuan in Series A financing.
It is jointly invested by Huayu Venture Capital, Fenghui Liuhe Bridge and Yuhang Supply and Marketing Group.

This quarter’s potential investment database contains 1020 major foreign financing events, accounting for 1020/1077 in last quarter.

. In terms of field, there were 32 traffic trips, amounting to US$ 8.582 billion; 198 cases of medical and health care, 6.453 billion US dollars; 265 enterprise applications, with a total cost of 5.956 billion US dollars; 139 cases of artificial intelligence, US$ 5.081 billion; 152 Internet applications and services, US$ 3.865 billion; 118 cases of finance, 2.345 billion US dollars; Other 42 cases, 1.859 billion US dollars; 29 life services, 652 million US dollars; 14 cases of agriculture, 646 million US dollars; 22 intelligent hardware, 539 million US dollars; 20 education, 354 million US dollars; 5 sports and fitness, 326 million US dollars; 14 express logistics, 306 million US dollars; 6 advertising marketing, 256 million US dollars; 6 tools, 167 million US dollars; 7 purchases, 147 million US dollars; 5 socializations, 144 million US dollars; 12 cases of real estate, 112 million US dollars; 10 games, 80.5 million US dollars; 11 tours, 55.0634 million US dollars; 5 homes, 54 million US dollars; 3 cultural entertainment, 18.9 million US dollars; 3 blockchain, 18.01 million US dollars; 1 autopilot, 6 million US dollars; 2 pieces of media information, 2.5 million US dollars.

In terms of rounds, there are 13 rounds of D, with a total cost of 1.546 billion US dollars; 1 angel wheel, 10 million US dollars; 3 rounds of Pre-B, 59 million US dollars; 5 rounds of E, with a cost of 675 million US dollars; 39 rounds of C, 2.871 billion US dollars; 225 seed rounds, 1.23 billion US dollars; 77 rounds of B, 3.592 billion US dollars; C+ 3 rounds, 86.6 million US dollars; 111 acquisitions, 621 million US dollars; 127 undisclosed cases, 9.316 billion US dollars; A round of 158, 3.002 billion US dollars; 53 Pre- seed rounds, 2.592 billion US dollars; E round and two later rounds, 235 million US dollars; 6 A+ rounds, 73.8 million US dollars; 184 strategic investments, amounting to US$ 6.749 billion; 11 rounds of Pre-A, 36.2064 million US dollars; One B+ round, 44 million US dollars; One round of F, 30 million dollars.

Of the 1020 financing events, 322 were over 100 million yuan, accounting for 0.91%. Among them, there are 91 cases of medical and health care, 78 cases of enterprise application, 49 cases of Internet application and service, 41 cases of artificial intelligence, 38 cases of finance, 18 cases of others, 11 cases of transportation, 9 cases of intelligent hardware, 9 cases of express logistics, 8 cases of life service, 6 cases of agriculture, 6 cases of education, 4 cases of social interaction, 3 cases of shopping, 3 cases of real estate, 2 cases of advertising and marketing, 2 cases of games and 2 cases of sports and fitness. At the top of the transaction amount this quarter was GreenCell Mobility from India, which received investment financing of 4.65 billion rupees from REC.

Regionally, there are 558 cases in the United States, 101 cases in Britain, 47 cases in India, 37 cases in Germany, 32 cases in Israel, 31 cases in Canada, 21 cases in France, 19 cases in the Netherlands, 17 cases in Switzerland, 15 cases in Singapore, 11 cases in the United Arab Emirates, 10 cases in Spain, 9 cases in Indonesia, 9 cases in Finland, 8 cases in Nigeria, 8 cases in Sweden, 8 cases in Ireland and Australia. South Africa 4, Belgium 4, Italy 4, Turkey 4, Kenya 3, Argentina 3, Saudi Arabia 3, Japan 3, Lithuania 3, Norway 3, Austria 3, Mexico 3, Iceland 2, Poland 2, Czech 1, Jordan 1, Malaysia 1, Vietnam 1, Czech Republic 1, Dubai 1 and Myanmar 1.

　　Zhongxin Jingwei Client October 11 (Dong Xiangyi) Although the property market has not been booming in the "Golden Week" this year, Xuzhou, Jiangsu Province took the lead in launching regulatory policies just after the National Day holiday, followed by Shaoxing, Zhejiang Province. The policies of the two places focus on the record price management of commercial housing, and at the same time, they also clarify the restrictions on sales, "land price restrictions, and competitive construction". According to institutional data, the number of national real estate control policies in the first nine months of this year was as high as 403 times.

　　According to the analysis, the policies issued by Xuzhou and Shaoxing further illustrate the orientation of not relaxing regulation. Especially in the fourth quarter, the national housing enterprises will actively promote sales and destocking, and it is also crucial to stabilize the market order at this time. It is expected that there will still be regulation and control throughout the country in the fourth quarter, focusing on the implementation of the "three stable" policy. In addition, the promotion of real estate enterprises will still have a certain driving effect on the transaction, the overall decline of the market scale can be controlled, and the house price will still be stable.

　　At the same time, the strict implementation of the "three red lines" will be postponed until 2023, which is also confirmed by the media as a misunderstanding and will still be fully implemented in the whole industry from 2021. As for whether it affects housing prices, in the opinion of experts, since the current policy has definitely not landed, it will have no impact on the market.

　　Xuzhou and Shaoxing introduced regulation after the festival.

　　Start the property market "double cannon"

　　On the evening of October 9th, official website of Xuzhou Housing and Urban-Rural Development Bureau issued the Notice on Further Promoting the Healthy Development of Urban Real Estate Market, which clarified many aspects such as homestead supply, filing price management, decoration behavior and price supervision, real estate financial policy, commercial housing sales restriction, housing security and so on.

　　The notice is clear, and the management of the sales price of commercial housing should be strengthened. Newly-filed commercial residential projects with a parcel construction area of less than 100,000 square meters shall be filed at a one-time price; If the parcel construction area is higher than 100,000 square meters, the price can be put on record by stages, each time the record is not less than 100,000 square meters, and the last period is less than 100,000 square meters, so the record can be made according to the facts; The filing price shall not be adjusted within one year.

Source: Xuzhou Housing and Construction Bureau website

　　Xuzhou also stipulates that all financial institutions should strengthen the examination of the use of credit funds and the detection of the flow direction, and take various effective measures to prevent consumer loans and other loans from being used for buying houses in violation of regulations.

　　Xuzhou’s policy of "continuing to adhere to the policy of restricting commercial housing transactions" is not new. According to the Notice on Improving the Opinions on the Stable and Healthy Development of the Urban Real Estate Market in Xuzhou in June 2018, the sales restriction policy had been implemented at that time.

　　Yan Yuejin, research director of the think tank center of Yiju Research Institute, told Zhongxin Jingwei that even if the policy content is reiterated, it will continue to release the signal of policy tightening, at least similar to the constraint of six-year sales, and it can also regulate housing transactions and prevent all kinds of housing speculation, which also makes the effect of the sales restriction policy further amplified.

　　According to the housing price data of 70 cities released by the National Bureau of Statistics in August, the sales price of new commercial housing in Xuzhou increased by 0.8% month-on-month and 11.6% year-on-year, second only to Yinchuan, Tangshan and Xining. The sales price of second-hand houses increased by 0.8% month-on-month and 7.3% year-on-year.

　　According to the data of Xuzhou Yibaifang, in the first three quarters of this year, the total land transaction income in Xuzhou reached 37.28 billion yuan, up 73% year-on-year, ranking 29th in the country. Quarterly, in July, August and September alone, the total amount of land transactions in Xuzhou was close to 12.5 billion yuan.

　　"The introduction of this policy in Xuzhou further illustrates the orientation of housing prices and expected stability." In Yan Yuejin’s view, Xuzhou’s latest new commodity housing price index rose fourth year-on-year in the country, which belongs to a city with overheated housing prices, so the policy was introduced in line with expectations.

　　On the same day, Shaoxing, a prefecture-level city in Zhejiang Province, followed Xuzhou and became the second city to be upgraded and regulated after the National Day holiday. According to data from the Central Plains Real Estate Research Center, Shaoxing is the 27th city in China to tighten control policies.

　　The website of Shaoxing Housing and Construction Bureau issued the Notice on Further Promoting the Smooth Operation of the Real Estate Market, emphasizing the strict implementation of the policy of "limiting land prices and competing for construction", the strict implementation of the "double filing" system, the strict management of sales by stages, the strict regulation of market order and the strict implementation of the main responsibility.

Source: website of Shaoxing Housing and Construction Bureau

　　The most important policy is to strictly implement the "double filing" system. The price filing of newly opened projects must comprehensively consider other similar housing prices or "land price+cost" and other factors in the same region, and the price filing of additional projects shall not be higher than the price of commercial housing for the first time.

　　Some analysts believe that this provision means that the developer’s autonomy is compressed, and the decision-making power of filing price tends to be regulated by the government. For developers, the filing price will be more scientific and reasonable, and will be subject to stricter supervision, and the filing price will not fluctuate greatly; For property buyers, the price of the real estate on sale will also be effectively controlled, and there is no need to worry about the ups and downs of housing prices.

　　In addition, for those who have obtained the pre-sale permit or filed the sale of existing homes, all the houses to be sold and the price of each house shall be disclosed at one time within ten days, and shall not be sold at a price higher than the declared price. In addition, increase land supply and implement differentiated land supply. Strictly implement the policy of "limiting land price and competing for construction" and strictly control premium rate and floor land price.

　　Yan Yuejin pointed out that from the content of Shaoxing’s property market policy, references to similar restrictions on purchases and loans are reduced, but more are aimed at land prices and housing prices. This also shows that in the current special period, we are still encouraging housing transactions, but we should guard against the speculation of land prices and housing prices.

　　However, institutional data show that there is no sign of rising house prices in Shaoxing recently. According to the data of Fangtianxia, the average reference price of second-hand houses in Shaoxing in September was 9436 yuan/flat, down 9.29% from August and 21.65% from the same period last year.

Photo by Xin Jingwei in the data map

　　The influence of policies in the two places is limited.

　　The national real estate regulation reached 403 times.

　　"These policies are all lively, not fundamental, and credit has not been fully tightened." Zhang Dawei, chief analyst of Zhongyuan Real Estate, told Zhongxin Jingwei reporter, "Looking at the contents of the regulation policies of these two cities separately, they are close to those of most cities, and the actual regulation policies are not strong, mainly due to the tightening of the filing price adjustment, which is expected to have a certain impact on the market. However, the impact is limited. "

　　Yan Yuejin said that after the "Eleventh" holiday, including the introduction of policies in Xuzhou and Shaoxing, further explained the orientation of not relaxing regulation. Especially in the fourth quarter, the national housing enterprises will actively promote sales and destocking, and it is also crucial to stabilize the market order at this time.

　　At the same time, after the festival, it was also reported that the strict implementation of the "three red lines" will be postponed until 2023. According to shanghai securities news, the news is suspected of being misread, and the "three red lines" policy has not been extended, and will still be fully implemented in the whole industry from 2021.

　　According to media reports, "three red lines" means that the asset-liability ratio of real estate enterprises after excluding advance payments shall not be greater than 70%; The net debt ratio of housing enterprises shall not be greater than 100%; The "cash short debt ratio" of housing enterprises is less than 1.

　　With the gradual tightening of the financing end of real estate enterprises, the probability of developers increasing discounts and promotions in order to reduce debts is greatly increased. As for whether it directly or indirectly affects housing prices, in the opinion of experts, it is certain that the policy has not landed now, so it has no impact on the market. It is not too late to see the impact when the policy is implemented in the future.

　　In the third quarter of 2020, the central government held several meetings to emphasize that the positioning of "housing and not speculating" remained unchanged, and regulatory measures were deployed from various aspects. Since July, many cities have tightened their control policies, such as Hangzhou, Ningbo, Shenzhen and Chengdu, to stabilize market expectations. From the perspective of regulatory content, the policies introduced by various localities are mainly manifested in restricting purchases, upgrading loans, increasing the number of years of restricted sales, increasing the number of years of exemption from value-added tax, strengthening the management and control of the land market, strengthening market supervision, and clarifying that high-level talents and families without houses have priority in buying houses, so as to ensure just-needed and curb real estate speculation.

　　According to the statistics of the Central Plains Real Estate Research Center, the total number of real estate regulation and control in the country in September this year was 35 times. From July to September alone, more than 27 cities issued more than 30 regulation and tightening policies; From January to September, the national real estate regulation and control policies totaled 403 times.

　　Zhang Dawei believes that although the tightening of regulation policies in August and September is not strong, it still represents the trend of real estate regulation and control, that is, one city, one policy, no speculation in housing, and maintaining the stability of the real estate market. As long as it rises too fast, it will inevitably lead to regulation and upgrading.

　　The latest report "Summary and Trend Outlook of China Real Estate Market in the Third Quarter of 2020" released by the Central Finger Research Institute points out that looking forward to the fourth quarter, some cities with strong expectations of rising house prices and land prices will further upgrade their property market policies to stabilize their expectations, but with the gradual emergence of policy effects, the space for policy tightening has been significantly reduced. Some cities will further increase the efforts to attract talents and relax the restrictions on settlement in terms of increasing housing subsidies and strengthening housing security, which will further promote the development of the real estate market.

　　Golden week property market eclipsed.

　　How to get the house price in the fourth quarter

　　Judging from the statistics released by many institutions, the National Day holiday just passed did not give the property market too many opportunities for performance. The performance of "Silver Ten" was light, and the new and second-hand housing markets showed a scene of "uneven heat and cold". According to the analysis, with the increase of residents’ demand for tourism, buyers pay more attention to travel during the long holiday and pay less attention to the property market. In the past three years, the so-called National Day property market Golden Week has faded.

　　According to the monitoring data of Zhuge Housing Search Data Research Center, the sales area of new houses in 10 key cities (Beijing, Shenzhen, Wuhan, Suzhou, Dalian, Fuzhou, Qingdao, Dongguan, Wenzhou and Tai ‘an) was 728,600 ㎡ during the two holidays, a slight increase of 1.6% compared with last year’s National Day Week. On the whole, the sales volume of this year’s holiday is basically the same as that of last year. However, due to the fact that this year’s holiday is one day longer than that of previous years, the average daily sales area of the 10 key cities in 2020 is 91,100 ㎡, down 11.1% year-on-year. The average daily sales area is the lowest value of National Day Week since 2015.

Source: Zhuge looking for a house

　　In the second-hand housing market, the data released by RealData showed that among the 18 cities monitored during the Golden Week, the average daily transaction volume of second-hand housing increased by 50% compared with the same period of last year, and the average transaction price of second-hand housing increased by 12% year-on-year.

　　Zhang Dawei believes that the impact of the epidemic on the real estate market has passed, and the subsequent market will continue to heat up. However, the frequent occurrence of regulatory policies has kept the increase at a "warm" level.

　　According to the report of the Central Finger Research Institute, in the fourth quarter, the national real estate market will show a situation that "the market scale will be slightly adjusted, the enthusiasm for new construction will slow down, and the investment growth rate will remain at a high level". With the rational return of demand under the tightening of regulation and control, the market scale will return to the adjustment channel under the cyclical action, but the active promotion strategy adopted by real estate enterprises will still have a certain driving effect on the transaction, and the overall decline of the market scale can be controlled; The overall operation of house prices will remain stable, and the increase of improved products and the emergence of the advantages of first-and second-line products will drive the average selling price to continue to rise slightly. (Zhongxin Jingwei APP)

Tencent Video

Youku

Iqiyi

1905 movie network news Today’s news, the three major video portals, iQiyi, Tencent and Youku, issued a joint announcement to jointly resist inferior artists and jointly take the first step in the healthy management of video websites. The following is the text of the announcement.

As can be seen in the announcement, the three major video portals have noticed some worrying phenomena, and the "star effect" has been exaggerated; A small number of actors’ own behaviors are not standardized, which makes the original orderly creative environment appear disharmonious and unhealthy. For example, some actors’ "value-only theory" violates the market rules and offers sky-high pay, so they no longer concentrate on creation; The studio is passive and does not work according to the specified time; The "position-only theory" disrespects other creative members of the crew, puts forward abnormal requirements, alters scripts indiscriminately, interferes with the director’s shooting, and decides the actor’s collocation and replacement.

In addition, the announcement also emphasized that actors should be prevented from forcibly appointing co-directors, co-actors, deleting scripts and deciding their positions in order to highlight their personal scenes and not respecting the main context of script creation and the performances of other actors; Put an end to the phenomenon that actors don’t work hard to ensure the normal operation of the crew; Even, we will gradually establish a list of bad actors, including actors who violate the spirit of contract, misbehave, are not dedicated, put forward unreasonable demands, and disturb the normal shooting order of the crew. The three platforms will implement an early warning mechanism for such actors and employ them cautiously.

I don’t know if you "bad artists" are worried now.

　　■ Recently, some netizens said that on the short video platform, some people "recycle" banknotes, coins and food stamps at high prices. In the anchor’s mouth, coins in some years are as high as tens of thousands of yuan. Is this true or not? The reporter’s investigation found that most of the "high-priced recycling" is not worthy of the name. Some people use this as a gimmick to sell the so-called price list and promote mobile games.

　　High price recovery

　　"Free door-to-door recycling. Before door-to-door recycling, I will give you a 10% deposit first. If you want this fifty cents, I will pay you 29,000 yuan first … …”

　　Fudge with goods

　　The reporter’s investigation found that whether it is identification or recycling, it is necessary to buy a so-called "price list". Once the money is paid, there is often no movement for many days.

　　1 "Chaos"

　　On-line quotation of 10,000 yuan and offline discussion on the recovery of pounds.

　　"Hello, everyone, see if your family has this nickel, plum blossom, two cents, and chrysanthemum. If so, we can see which year and edition we want to receive, and we will receive the goods at home. " In a short video, the anchor is introducing the price of selling cents. As can be seen from the sample he showed, in 1986, a nickel was 14,000 yuan, in 1961, a nickel was 13,000 yuan, and a quincunx was 12,000 yuan … …

　　There are many anchors similar to "high-priced recycling" on short video platforms. "Let’s start to quote one by one now. 5 cents in 1984, 55,000 yuan each; Five cents in 1976, a 10 thousand; 2 points in 1985, 15 thousand pieces. Food stamps, receive national food stamps. " The anchor of an account said this in the live broadcast room. The other anchor is more generous, saying that as long as it meets the three-point requirement of a fifty-cent banknote, a piece of 290,000 yuan. "Free door-to-door recycling. Before door-to-door recycling, I will give you a 10% deposit first. If you want to have this fifty cents, I will pay you 29,000 yuan first, and the staff will pay you the final payment after the door. "

　　Online "high-priced" acquisitions, what is the offline situation? The reporter found that there are many merchants engaged in coin collection and recycling in a postal currency card market near Madian Bridge in Beijing’s North Third Ring Road. Here, dividing money is often "on the weight of income."

　　Some merchants said that the recycling price of cents or banknotes mainly depends on the year and edition, and the price will not be too high. The so-called "high-priced recycling" on the Internet is actually very rare in individual years. Only when there may be no coins in circulation in that year can there be that price. "Well, many cents are mixed in years, and now we are collecting by the pound." The merchant said that the current price is about a catty of 70 yuan; In terms of selling, it is basically a dime to two cents. "What he said is only possible in a few years. If you think about it, it’s definitely not that valuable. Let’s sell it outside, too. Another one, they are actually eyeballs, in order to increase the click-through rate. "

　　2 "actual measurement

　　If you want to sell coins, you need to buy a price list first

　　The so-called "high-priced recycling" or gimmicks, but if you really want to sell coins to these anchors, how to trade? The reporter’s investigation found that whether it is identification or recycling, it is necessary to buy a so-called "price list". Once the money is paid, there is often no movement for many days, and it is suspected by netizens that it is profitable.

　　"How many people sell their coins by the catty? If so, you will lose a lot." An anchor who claimed to be engaged in coin collection for many years suggested that the audience take out the coins at home to see the year and characteristics, and wait for them to "collect them at home". When an audience asked how to contact, she said that she needed to buy a price list of coins first, and then send it directly to her address through the private message function. "I can only send me a home address if I grab the price list. I can’t do it without grabbing the price list."

　　The anchors of multiple "recycling" and "collecting" accounts are all similar rhetoric. Another collection account anchor said that the staff engaged in coin identification and recycling business all over the country, and the door-to-door recycling did not require users to bear transportation expenses and identification fees. However, there is a "threshold" for door-to-door identification and recycling — — Need to snap up the price list "Because the platform does not allow us to trade privately, we need to buy the price list first, and then the platform will push the order in real time, and we will contact you according to the order information." In the live broadcast, the anchor constantly encouraged everyone, "If you want to come to the door for identification, you must show some sincerity."

　　The names of the "price list" referred to by multiple account anchors are similar. Some are called "Latest Coin Recycling Price in 2022", while others are "Price List of Coins" and "Daquan of Coin Price List". Most of these price lists are priced around 20 yuan. Some price lists have been bought by 973 people, while others have been bought by nearly 500 people.

　　The reporter paid 20 yuan to buy a price list and found that the content was a video of a few minutes and the price list corresponding to the year of the coin. According to the guide of the anchor, the reporter left a specific address in the private letter after payment, but after many days, the private letter did not respond.

　　3 "routines

　　Induced download game

　　Hide all kinds of advertisements

　　Selling the so-called "price list" or one of the routines of "high-priced recycling" on the grounds that "the platform is not allowed to trade privately" in the live broadcast of coin recycling. What’s more, game advertisements are constantly implanted in the live broadcast to induce viewers to download mobile games to "make money".

　　On a short video platform, an anchor with 1.8 million fans, hundreds of videos released before were short videos of life. Recently, there has been a continuous live broadcast explaining the relevant knowledge of coin recycling.

　　At 10 o’clock in the evening, there are at most 300 people online in the live broadcast room of the anchor. "2 cents in 1985, 151 pieces; In 1953, 1 cent paper money, double Roman numerals, 90,000 yuan each … …” This anchor speaks very fast and looks very professional.

　　Just when everyone was listening, he suddenly "changed" — — "Anchor anchor, I ‘ Raising pigs ’ Earned 500 yuan to the account. Yes, brothers, raising pigs can make money now. " Subsequently, the anchor began to introduce the mobile pig-raising game on the live page. He said that he "raised" 10 pigs and earned more than 200 yuan in 30 minutes. "As long as you have enough time for 20 minutes, you can earn 150 yuan, and the cash will be paid in seconds. Don’t let you invest, don’t let you spend money on feed, and don’t consume your traffic. " The anchor also showed the page that after downloading "Pig Raising", some users in their live broadcast room earned 500 yuan, some earned 3,000 yuan, and some earned 10,000 yuan. "Click on the yellow bell below the live room to download and install it on the mobile phone."

　　The reporter downloaded a "pig-raising" game recommended by the anchor, and found that after the installation, it is necessary to authorize WeChat to log in. During the trial play, clicking on multiple props on the page may pop up various types of embedded advertisements, and prompt for receiving benefits. It is also quite laborious to quit the advertisement. However, the 43 yuan red envelope obtained after playing the game for a few minutes has a small line "You can withdraw all 1% of the red envelope". To improve "productivity", we should watch more advertisements and invite more friends.

　　4 "Reminder

　　false advertising

　　Beware of recycling the chain cover

　　"The so-called ‘ High-priced recycling ’ Coins, food stamps, etc., as far as I know, may be ‘ Sell dog meat by hanging sheep’s head ’ . He actually mainly sells the so-called ‘ Price list ’ , rarely really recycle. If you really have some cents or food stamps designated by him, you will often be introduced to the auction and you have to pay money, which is a bit ‘ Chain sleeve ’ The meaning. " Zhu Wei, deputy director of the Communication Law Research Center of China University of Political Science and Law, said.

　　Zhu Xi analyzed that some anchors sell price lists with the gimmick of "high price recycling", which actually allows consumers to buy goods on the basis of misunderstanding. According to the Law on the Protection of Consumer Rights and Interests, this is a fraud, and it needs to be "refunded for one and compensated for three". If it is less than 500 yuan, it needs to be compensated according to 500 yuan. The recommended game is basically "using the game as a carrier for advertising, which belongs to the old routine." Zhu Wei believes that these games are more likely to mislead the elderly, and it is necessary to strengthen the registration mechanism, prompt mechanism, exit mechanism, rejection mode and personal information protection of the games.

　　Zhu Wei believes that short video platforms often have no way to distinguish between true and false content, but it is not without responsibility. According to the "Measures for the Supervision and Administration of Online Transactions", as long as there are goods hanging on the "little yellow car" in the live broadcast, the live broadcast playback must be kept for three years; At the same time, the anchor must be certified by real name; In addition, the platform should handle reports from users in a timely manner, and it should also conduct self-inspection at ordinary times. "Once the live broadcast involves violations, you can limit the flow and suspend the live broadcast rights until the title."

　　According to Beijing Daily client

Since its launch on February 24th, Hubei Health Code has received enthusiastic attention from the masses and actively applied for it. As of April 1st, 44.16 million Hubei health codes have been issued, with the highest number of visits in a single day exceeding 25 million and the cumulative number of visits exceeding 4 billion.

On March 11th, the provincial epidemic prevention and control headquarters issued the "Forty Questions of Hubei Health Code". Recently, in view of the related questions collected by 12345 hotline and online consultation, we are now focusing on answering the questions of the masses in the collection of Hubei health codes.

1. How was the Hubei health code issued?

Hubei health code is assigned according to the applicant’s health status records in the epidemic database during the epidemic prevention and control period, and with reference to the health status filled in by individuals. For confirmed, suspected, asymptomatic infected people and people with fever in Wuhan, a red code will be issued; For those who are diagnosed, suspected or have fever by close contact and self-filling, a yellow code will be issued; For people with fever in non-Wuhan area, no code will be assigned within 7 days; Issue green codes to those who do not belong to the above situation.

2. I am a red code (yellow code) now. How can I change to a green code?

You can fill in the transcoding application through the "Hubei Office" APP, Alipay and WeChat applet. County (city, district) prevention and control headquarters audit, and report to the city (state) prevention and control headquarters for review, and turn green after the review. Fever personnel who are not transferred to the confirmed, suspected and closely connected will be automatically converted to green code after 7 days.

3. How long does it take to apply for Hubei health code?

People in medium-risk areas (Wuhan) will be assigned codes within 12 hours after applying for health codes. After people in low-risk areas apply for health codes, they will be assigned codes within 4 hours. In order to further improve the efficiency of traffic, after completing the health registration, the background will review the code as soon as possible.

4. Health codes in some provinces need to be punched in every day. Do health codes in Hubei need to be punched in?

No need. For the convenience of the masses, on March 22nd, Hubei Health Code cancelled the daily punching function.

5. My health code is scanned and verified. Will my personal information be leaked?

No. The personal information of Hubei health code has been encrypted and desensitized strictly, and the staff can only get the color and check information of health code by scanning code verification. The design of scanning code function fully considers the protection of personal privacy.

6. Do I have to apply for Hubei Health Code when I come to Hubei from other provinces?

According to the notice issued by the provincial epidemic prevention and control headquarters on March 19th, people with health codes from other provinces in Hubei Province were given "bright codes". You can also apply for Hubei health code, which is convenient for bright code verification in public places and community channels in the province.

7. Is the distribution of health codes in Hubei related to high, middle and low risk areas?

At present, according to the requirements of zoning and grading, accurate prevention and control, health codes are issued only for people with fever to distinguish between medium and low risk areas. Among them, the red code will be issued to the fever personnel in Wuhan, and the fever personnel outside Wuhan will not be given the code for the time being.

8. Why did I go to the fever clinic and the green code turned red?

According to the requirements of the provincial epidemic prevention and control headquarters, the red code will be issued to the registration personnel of Wuhan fever clinic.

9. I heard that applying for Hubei health code is related to whether the mobile phone is turned on or not and tracking the whereabouts.

It’s okay. The application for health code in our province is strictly in accordance with relevant laws and regulations, and the tracking information of the applicant’s mobile phone is not collected.

10. I heard that people with Hubei health code green code were found in Foshan, Guangdong and Lanzhou, Gansu, and were diagnosed. Did you send the wrong code?

At the beginning of the distribution of health codes in our province, red codes were distributed to those who were positive for nucleic acid testing (including asymptomatic infected people). The newly-added cases in Guangdong and Gansu have no symptoms before traveling, and they have been isolated for more than 40 days, and they do not belong to the "four categories of people" who are diagnosed, suspected, closely connected and have fever. It is in line with the coding rules to issue green codes to them.

(The original title is "Will scanning code reveal personal information? The green code turned red? Hubei Health Code Ten Questions and Ten Answers ")

(This article is from The Paper, please download the "The Paper" APP for more original information)

　　Beijing, March 16 (Reporter Jing Wong) Fu Linghui, spokesperson of the National Bureau of Statistics and director of the National Economic Statistics Department, said at the press conference on the operation of the national economy in January and February held on the 15th that since the beginning of this year, with the rapid and smooth transition of epidemic prevention and control, the effect of stabilizing the economy has continued to appear. From January to February, the overall economic operation showed a trend of stabilization and recovery, which was characterized by the recovery of production demand, the overall stability of employment prices, the gradual improvement of economic cycle, and the increasing vitality of market players.

　　Looking specifically at the "troika" that drives economic growth, the reporter is concerned that in terms of investment, the investment in public facilities management has increased by 11.2%. In addition, the consumer market has recovered, and the sales in rural markets have recovered better than those in cities and towns.

　　The State Council held a press conference on the operation of the national economy in January and February (Source: Guoxin. com)

　　Investment: The substantial growth of manufacturing industry lays a good foundation for increasing employment.

　　Since the Central Economic Work Conference held at the end of 2022 reiterated "Two Unswervings", private economy and private enterprises have been frequently mentioned. This year’s "Government Work Report" also proposes to protect the property rights and entrepreneurs’ rights of private enterprises according to law, encourage and support the development of private economy and private enterprises, support the development of small and medium-sized enterprises and individual industrial and commercial households, and build pro-Qing political and business relations.

　　In terms of investment, the latest data released by the National Bureau of Statistics on the 15th showed that infrastructure investment increased by 9.0% year-on-year in January-February, among which investment in public facilities management increased by 11.2% and investment in railway transportation increased by 17.8%. Investment in manufacturing increased by 8.1%, and investment in electricity, heat, gas and water production and supply increased by 25.4%.

　　"In January and February, the national investment in fixed assets (excluding farmers) was 5,357.7 billion yuan, up 5.5% year-on-year, 0.4 percentage points faster than the whole year of 2022. In terms of industries, the investment in the secondary industry increased by 10.1%. Originally, I thought that consumption should be the mainstay in January and February. I didn’t expect that under a series of policy blessings, the most beautiful thing was investment, and the most beautiful thing in investment was manufacturing. " Pan Helin, co-director and researcher of Digital Economy and Financial Innovation Research Center of International Joint Business School of Zhejiang University, analyzed that the substantial growth of manufacturing industry reflects the economic confidence of ordinary people, and lays a good foundation for future economic development and employment.

　　In terms of real estate that has attracted much attention, Fu Linghui analyzed that this year, under the influence of a series of policies, with the economic warming, there have been some positive changes in the real estate market, mainly in the obvious narrowing of the decline in market sales.

　　Specifically, in January and February, the sales area of real estate decreased by 3.6%, which was significantly narrower than last year. Sales decreased by 0.1%, which also narrowed significantly. At the same time, real estate enterprises are also improving in terms of in-place funds and start-up investment. From January to February, investment in real estate development dropped by 5.7%, compared with a drop of 10% last year.

　　"From these situations, there have been some positive changes." On the whole, Fu Linghui said that the real estate market is still in the adjustment stage. Later, with the gradual improvement of the overall economy and the expected improvement of the market, the real estate market is expected to gradually stabilize.

　　Data Map: Chaoyang District, Beijing launched consumption promotion activities, and shopping malls created spring scenery to attract consumers.

　　Consumption: compared with last year, the economic growth has been significantly improved.

　　In order to promote economic growth in 2023, the recovery of consumption and even strong growth are highly anticipated. Fu Jiaqi, statistician of the Department of Trade and Economics of the National Bureau of Statistics, said that in January and February, the market sales increased year-on-year, the consumption of contact and travel services picked up rapidly, the demand for upgraded consumption continued to be released, and new consumption patterns stimulated consumption vitality.

　　According to the latest data released by the National Bureau of Statistics, the total retail sales of social consumer goods in China in January and February was 7,706.7 billion yuan (RMB, the same below), up by 3.5% year-on-year, and decreased by 1.8% in December 2022. Fu Linghui said at the press conference of the State Council Office that the total retail sales of social consumer goods has changed from decline to increase, indicating that the vitality of market demand is picking up.

　　"The consumption performance in January and February is in line with expectations. In the coming months, the consumption trend should be greatly improved year-on-year, and the chain may drop slightly, because the Spring Festival tourism consumption in January and February has really boosted." However, Pan Helin also said that with the gradual expansion of domestic demand in policy, consumption will return to the stage of rapid growth after May.

　　When talking about the demand for economic growth this year, Fu Linghui also said that at present, the policy focus this year is to expand domestic demand. At present, on the whole, consumption will significantly improve and enhance the economic growth in 2023 compared with last year. The restraining factors of consumption are gradually eliminated. With the gradual recovery of employment and the growth of residents’ income, the pull of consumption on the whole economy will be obviously improved. At the same time, the pulling effect of investment on economic growth continues to show.

　　In 2023, many departments are also making efforts to promote consumption. Take the Ministry of Commerce as an example. On February 2, the Ministry of Commerce clearly defined 2023 as the "year of boosting consumption". It is proposed that according to the new situation this year, we should focus on key areas such as automobiles and home furnishing, and promote the introduction of a number of new policies to maximize the effectiveness of policies. Pan Helin also pointed out that the overall consumption data in January and February is still lower than the same period of the previous year, reflecting that domestic consumption expenditure is still in the recovery stage; From January to February, the retail sales of social goods deducted from automobile sales was 5%, reflecting that the fluctuation of automobile sales also disturbed consumer spending.

　　Fu Linghui said that this year’s policy focus is still to expand domestic demand. At present, from the perspective of the whole international environment, there are still many unstable, uncertain and unpredictable factors. In order to promote the stable development of the economy, we should focus on our own development and promote the expansion of domestic demand to stabilize economic growth.

　　Data Map: On March 10, 2023, the aerial photography of Haikou Port Container Terminal was a busy scene.

　　Export: there are challenges and many favorable conditions for foreign trade to promote stability and quality throughout the year.

　　In order to stabilize the basic market of foreign investment and foreign trade, the "Government Work Report" listed "attracting and utilizing foreign investment more vigorously" as one of the eight key suggestions of the government’s work this year, and "promoting stability and quality through import and export, and basically balancing the balance of payments" as the main expected goal of this year’s development.

　　In terms of import and export, according to the data of the National Bureau of Statistics, in January and February, the total import and export volume of goods was 6,176.8 billion yuan, down 0.8% year-on-year. Among them, the export was 3,493.6 billion yuan, up 0.9% year-on-year, 9.6 percentage points lower than the annual growth rate in 2022; Imports were 2,683.3 billion yuan, down 2.9%, down 7.2 percentage points from the annual growth rate in 2022.

　　The data released on the website of the General Administration of Customs on March 7 also showed that in the first two months, the import and export growth to ASEAN declined to the EU, the United States and Japan. Among them, the total trade with ASEAN was 951.93 billion yuan, up 9.6%, accounting for 15.4% of the total foreign trade (the export to ASEAN increased by 17.9%), making it the largest trading partner. Exports to the EU, the second largest trading partner, reached 552.83 billion yuan, down 5%; Exports to the United States, the third largest trading partner, reached 494.11 billion yuan, down 15.2%. Exports to Japan, the fourth largest trading partner, reached 183.56 billion yuan, an increase of 6.7%; Imports reached 161.36 billion yuan, down 16.8%.

　　The global trade outlook report released by WTO in October 2022 predicts that the global trade volume of goods will only increase by 1% in 2023; In December 2022, the Global Trade Update issued by the United Nations Conference on Trade and Development pointed out that since the second half of 2022, the growth rate of global trade has begun to slow down, and the trend of slowing down trade growth in 2023 may continue.

　　Fu Linghui said that the external demand situation in 2023 is more severe than last year. Because the overall growth of the world economy has slowed down compared with last year, external demand may weaken. Recently, the manufacturing PMI of the United States and the euro zone is below the critical point, and the adjustment and change of external demand will inevitably have a certain impact on China’s import and export. Superimposed last year, the growth base was relatively high, and the total import and export volume in January and February decreased by 0.8% year-on-year, which is very difficult. "There are certain challenges in promoting the stability and quality of foreign trade throughout the year, but there are also many favorable conditions. On the whole, we are full of confidence in the development of foreign trade. " He said.

Xinhua News Agency, Beijing, September 29th (Reporter Zhao Wenjun) The reporter learned from the third quarter press conference of the General Administration of Market Supervision on the 29th that in order to speed up the market access of export products for domestic sales, in the field of certification supervision, measures such as "the same line, the same standard and the same homogeneity" have been implemented for export products of export enterprises, which are applicable to the fields of general consumer goods and industrial products.

The person in charge of the relevant departments of the General Administration of Market Supervision introduced that the first is to speed up the market access for domestic sales. Before the end of 2020, enterprises are allowed to sell in a way that they declare themselves to meet mandatory national standards. We will open a fast track for domestic production and sales approval, optimize the approval service for export-to-domestic products managed by the licensing access system for industrial products and special equipment production units, streamline the process and shorten the time limit. Streamline and optimize the compulsory product certification (CCC certification) procedures for products exported to domestic market, open up a green fast track, accept the existing conformity assessment results, expand online services, shorten the certification time limit, reasonably reduce the certification fees for products exported to domestic market, and comprehensively provide certification services and technical support.

The second is to implement the "three similarities" between domestic and foreign products of export enterprises. "Three similarities" means "the same line, the same standard and the same homogeneity", which means that export enterprises produce export and domestic products on the same production line according to the same standards, so that the products supplied to the domestic market and the international market reach the same quality level. To play the role of market mechanism, enterprises can make self-declaration on their products that meet the requirements of relevant standards of China and importing countries (regions) in accordance with the requirements of relevant national standards, or entrust third-party institutions to conduct relevant quality evaluation, and take the initiative to accept the supervision of social supervision and market supervision departments. Help export enterprises build a domestic promotion platform, accurately meet consumer demand, and provide all kinds of "three-in-one" products for the society.

In August this year, the General Administration of Market Supervision announced the list of market supervision departments that have been granted the right to register and manage foreign-invested enterprises nationwide, which is convenient for enterprises to inquire. Up to now, a total of 706 market supervision departments in China have been granted the right to register and manage foreign-invested enterprises. In order to make it easier for foreign-invested enterprises to register locally, the General Administration of Market Supervision is organizing centralized authorization for the registration of foreign-invested enterprises in cities at prefecture level and above.

In order to improve the consistency and create an open and fair standardization environment, the General Administration of Market Supervision has made it clear that domestic and foreign-funded enterprises will participate in standardization work fairly and break down the institutional obstacles for foreign-funded enterprises to participate in standardization work. Since the beginning of this year, nearly 100 foreign-funded enterprises have participated in the revision of national standards.

　　In July, thousands of college graduates are about to devote themselves to new roles. In the noise of parting, there is such a group of people standing in the corner who have been silent. This is an increasing number of depressed patients in colleges and universities. They are suffering from pain, loneliness and isolation that ordinary people can’t understand. It is really difficult for him to finish his graduation thesis and find a decent job at the moment. A recent survey by the reporter of Beiqing Daily found that 40 people in a famous key university in Beijing were diagnosed with depression, accounting for about 20% of the visits of the school psychological counseling center. College students with high intelligence and strong desire to win have become a high-risk group of depression.

　　survey

　　Depressed students account for 20% of the visitors to the counseling center.

　　"Hello, this is the psychological hotline for college students who cherish their lives in Li Jiajie. Can I help you?" A fixed opening remark, at the moment when the phone was connected, the receiver hesitated for several seconds and slowly spit out: "Hello, I want to consult some questions related to depression. I have been insomnia for 3 months … …” Xiao Qing, a student volunteer who has been connected for three years, still feels nervous and sweaty when she meets a caller who claims to be depressed.

　　Since the opening of "Li Jiajie Cherish Life Psychological Hotline for College Students" for 7 years, this hotline has listened to the voices of nearly 10,000 people from all over the country. Qin Lin, director of the hotline, told Beiqing Daily that the reporter would receive nearly three or four students’ radio waves for help every six hours online. Zhang Wen (pseudonym), the head of another mental health education center of a famous university in Beijing, said: "According to rough statistics, five years ago, one or two of the 10 clients had depression on average, but now it has risen to 3-4."

　　At present, colleges and universities in Beijing generally have mental health centers, which are mainly responsible for psychological investigation, mental health education, psychological classes and counseling. The school also arranges full-time psychological teachers and is equipped with special counseling centers. Here, although you can’t make clinical diagnosis like a professional hospital, it is the first "defense line" to prevent crisis and screen depression.

　　When talking about the group of college students suffering from psychological crisis, Zhang Wen, who has been working in the front line of university psychological counseling for a long time, bluntly said: "Among them, depression accounts for a relatively high proportion. Last year, there were about 1,500 visitors to the center, and depression accounted for 20% of the number of consultants. According to our statistics, a total of 40 students in the school were diagnosed with depression, and this number should be even higher if they were actually sick but did not come to consult. "

　　When these students come, they often talk about trifles such as "I’m under a little pressure to study recently", "How is it with my tutor (friend)" and "I’m lovelorn". Only when they completely let their guard down can they transition to a deeper topic: "Summarizing can be divided into four categories: study, interpersonal love, family and questioning the meaning of life." Regarding the psychological crisis of students, the situation of each school is different, and different types of colleges and universities face different problems. "Art universities focus on emotional issues, while comprehensive key universities focus on academics."

　　Depression, as a mental illness, has obvious abnormal reactions in emotion, cognition, motivation and physiology, and it is usually in the above aspects to judge whether it is sick or not. "If you lose interest in life, you will feel meaningless. In serious cases, you will have suicidal tendencies." Zhang Wen remembers receiving a girl who had undergone psychological counseling for three and a half years. At that time, the girl couldn’t even remember a short sentence of more than seven words. "I am sick, and my body and mind are in great pain. It is often difficult for ordinary people to understand. Our process is to ask the symptoms first. If it is serious, it is recommended to refer me and inform my family members or teachers. If it is not serious, I will have psychological counseling."

　　"I’m not good enough" is a high-frequency word in the mouths of visiting students in the center. Contrary to the usual idea of "just study hard", key university students with excellent grades have already occupied a certain number of depressed groups. They are extremely strict with themselves and often show feelings of guilt and self-blame. "Many children I have come into contact with are smart and sensible, and they have a strong motivation to win. For a long time, emotions such as self-blame or anger have been suppressed, which makes them point their attacks at themselves. "

　　particular case

　　Unable to defend my thesis, I had to drop out of school.

　　When it was time to say goodbye after graduation, Xiaoyu (pseudonym), a third-year doctoral student, did not show up at this year’s reunion dinner. She was ill. On the long road of fighting depression, Xiaoyu’s thesis defense has been in the foreseeable future, and graduation can only be postponed. She said the disease had no wound and no bleeding. "If you are depressed, don’t push me. It’s riddled with holes and leaks everywhere."

　　Xiaoyu, a liberal arts major at a well-known university in Haidian, Beijing, has always been quiet and introverted, but she is extremely active on social networks and updates almost every day. Looking at Xiaoyu’s WeChat circle of friends, I generally don’t notice that she is suffering from depression, and it has been 5 years. When spitting in the circle of friends became a blatant way of "selling cute", few people noticed her loneliness and pain that was occasionally open. This New Year, she wrote the sentence "Accept the best and worst of yourself".

　　Since the master’s degree was diagnosed as depression, she has suffered from three diseases, twice at home and once during an exchange abroad. The latest illness was during the writing of a doctoral thesis, and she was troubled by the double pressure of thesis and employment. For several months, she often suffered from insomnia, and her physical condition became worse and worse, and depression struck again. "Attention drops, I can’t remember things, and I can’t write at all. I have eaten dozens of antidepressants and endured the side effects of nausea, weakness and soreness. These are mixed with the symptoms of depression itself, and life is worse than death. "

　　When asked why he got depressed, Xiaoyu was at a loss. "I wouldn’t be depressed if I knew the specific reasons for getting sick. It’s like a cold, and I accidentally got caught up." In the second year of her master’s degree, she suffered from insomnia all night. In panic, she kept asking herself why. Sleep disorder leads to paralysis of study. "Even when I cooked a jiaozi sticky pot, I had to make a profound self-criticism and then rose to self-doubt, ‘ You can’t even cook a jiaozi now! ’” After several urging from friends, she came to the school psychological counseling center. After receiving several counseling sessions, the psychological teacher suggested that she go to the Sixth Hospital of Beijing Medical University and was soon diagnosed with severe depression.

　　Zhang Teng (pseudonym), an undergraduate majoring in computer science, had a more tortuous and long process of diagnosis of depression than Xiaoyu. It was not until last semester of his senior year that he really "collapsed" before depression and dropped out of school to go home. "When I entered school, I didn’t like my university and major, and I had a psychological gap. In addition, my girlfriend who talked about long-distance love at that time was very confused and couldn’t get out of that sad mood. I began to look for all kinds of books to read and test, and suddenly I felt depressed. At first, neither my parents nor I believed it. When I was dying, I was so sick that I had to drop out of school. " Most of the cases of depressed college students interviewed by the reporter of Beiqing Daily have struggled in a vicious circle of "being strong before others and being depressed after others", and they are suffering from hidden depression.

　　characteristic

　　Feature 1

　　"Shame of illness" makes it difficult for students to get sick in school.

　　Zhang Tengtan, a former patient with severe depression, accepted many patients of the same age he had contacted, who were often reluctant to show others at the beginning. According to public statistics, the number of people who commit suicide in China is at least 130,000 every year, and 40% of them suffer from depression when they commit suicide.

　　Students interviewed at random generally feel that depression is not far away, but they don’t know much about its basic knowledge and diagnosis and treatment. Most of them understand it from previous media reports. Yang Fude, president of Beijing huilongguan hospital, said in an interview at the end of last year that the number of patients with depression in China currently exceeds 26 million. According to the data of epidemiological investigation carried out by general hospitals in Beijing, nearly 10% of patients have depression, and less than 10% of them have received specialist treatment.

　　Because psychological problems are hidden, it is difficult for teachers to find out if the parties avoid them. The difficulty of pre-screening students with depression in colleges and universities can be seen. Faced with these difficulties, Zhang Wen and Qin Lin both laughed. "It is unlikely that children who come to see us will go to extremes." They feel that the top priority is still "desensitization", so that students and parents can face up to mental illness instead of demonizing depression. "The number of students suffering from depression on campus is increasing year by year, but some students and even their parents will feel ashamed and deliberately avoid communication. Some children are seriously ill and even refuse to see a doctor."

　　Feature 2

　　Dr. Shuo’s depression has shown an upward trend.

　　Professor Lin Guirui, honorary president of Beijing University Psychological Quality Education Research Association, has been conducting research on "college students’ psychological crisis groups" for years. Through a large number of case studies, she found that these depression groups of college students have some commonalities, such as: the proportion of students with bad family relationships or parent-child relationships is relatively high; Although the proportion of graduate students is not high at present, it has shown an upward trend.

　　Compared with undergraduates, PhD students who have the same experience as Xiaoyu face more economic, academic or family problems, and they are under greater and more complicated pressure. Zhang Wen recalled that he had intervened in a crisis with a male doctor who didn’t take a bath for a month. "I have been studying for 6 years but I can’t graduate. The incentive is the impact of papers and tutors, and he can only drop out of school in the end. "

　　When Xiaoyu’s classmates talked about her, they admired and envied her talent and hard work, but felt that the girl pushed herself too hard. One year abroad, Xiaoyu once struggled to translate a 600-page English book during her illness. Xiaoyu’s tutor was considerate of his disciples and advised Xiaoyu not to be impatient and to listen to the doctor’s arrangement. Fish said, "I am sick. Although he doesn’t say anything, I know that he is in the same mood as his parents. If there is something wrong with the students who have worked hard to train, it will be a great blow to the mentor. "

　　Under the current university management system, the coverage of psychological education in colleges and universities for graduate students is far less than that of undergraduates. In view of the topic that graduate students’ mental health is not paid enough attention, an unnamed college psychological counseling teacher explained: "This situation has certain objective reasons, including the factors of institutional setup in colleges and universities. Generally speaking, the mental health center belongs to the academic department of colleges and universities, and the academic department is often responsible for the related problems of undergraduates, and it is of an assistance nature for graduate work. "

　　affect

　　Some employers will do psychological tests for entry.

　　In addition to the sense of shame, many college students interviewed at random also mentioned another hidden feeling of not wanting to go to psychological counseling: "If there is something wrong with my psychology here, will it let many people around me know, and will it affect my future employment?" Zhang Wen and Qin Lin’s answers dispelled the students’ concerns to a certain extent, because the psychological hotline and psychological consultation will never enter the students’ personal files.

　　"Keeping secrets for them is our professional requirement. Unless the student’s condition is very serious and has extreme behavior tendency, then we will definitely inform the school counselor and parents. At this point, we will explain it to the visitors before the consultation, and we will start our work with the consent. "

　　The reporter of Beiqing Daily noticed that mental health problems have been paid more and more attention by employers outside campus, and the psychological test for entry has become fashionable. Zhao Wen (pseudonym), a graduate, passed the written examination and interview of a public institution in the spring recruitment this year. During the physical examination, the unit asked her to go to the hospital for psychological evaluation besides physical examination. In the hospital, Zhao Wen met several job seekers who needed a mental health assessment test just like her. They were asked to fill out a psychological test. These topics involve mental health status, personality characteristics, marriage and family, studies and other closely related contents.

　　Afterwards, Zhao Wen learned that the doctor would make a preliminary conclusion according to the questionnaire, judge the current mental health status of the examinee, and speculate on the problems existing in the examinee’s body, work, life, family, study and other aspects. "Who can guarantee the authenticity of this questionnaire? If someone has been unable to find a job because of a psychological investigation and evaluation, is this a kind of discrimination and unfairness? "

　　A senior psychological evaluation expert said that employers often have different attitudes towards whether to have a psychological test when they enter the job. "48% of unit leaders think that the psychological health of candidates is more important than skills when recruiting. Even if the applicant is very capable, if there are psychological problems, the unit will give up. " However, he admits that there are indeed many units that ask them to do mental health assessment for new recruits, most of which are education, medical care, security and other units, and there are many job seekers who have been rejected because they failed the psychological test.

　　This edition/reporter Liu Xu

[Dry goods] Real estate sales forcing skills

"Dry goods" real estate online marketing plan summary

"Dry goods" real estate trading training (99ppt)

"Dry goods" PPT template for work summary work plan of marketing department　

[dry]Goods] work summary work plan PPT template　

"Dry goods" channel expansion and marketing required course (53ppt)

"Dry goods" selected PPT template (2000+ppt file)　

PPT template for work summary plan report and debriefing report

How Vanke subdivides customers and accurately locates them.

　　Cctv news: According to the message of "Healthy Hangzhou" on WeChat WeChat official account. On July 15th, the Hangzhou Municipal Health and Wellness Committee issued the "Circular on the Preliminary Investigation of Medical Accidents in Huayan Medical Beauty Hospital", which pointed out that after the expert evaluation organized by Hangzhou Medical Association, the death of liposuction infection in Hangzhou Net Red Wear was a medical accident. The full text of the bulletin is as follows:

　　On May 2 this year, Dai Moumou went to Huayan Medical Beauty Hospital for liposuction and other medical beauty operations. After the operation, he developed septic shock, and was fully treated by Greentown Hospital and Zhejiang Second Hospital, and finally died on July 13.

　　According to the expert evaluation organized by the Municipal Medical Association, this is a medical accident. Huayan Medical Beauty Hospital has some faults such as lack of understanding before operation, improper operation during operation, untimely observation and treatment after operation, etc., which has a causal relationship with the patient’s death, and has taken full responsibility and made compensation. At the same time, the Xihu District Health and Health Bureau imposed warnings and fines on the hospitals involved, instructed them to suspend business for rectification, and further dealt with the responsible medical staff.

　　Our city will draw inferences from this medical accident, strengthen the practice management of medical institutions, and intensify the rectification of medical beauty chaos.